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Chapter 1
Chapter1: Introduction
1.1 Background
1.1.1 Schizophrenia
Schizophrenia (SZ) is a mental disorder that profoundly alters the way in which people per-
ceive their external and “internal” worlds, and in turn, how they interact with them. “Positive”
symptoms refer to behaviors that are present in an individual with SZ that are absent from
the normal population and include delusions, hallucinations, and disorganized speech. Con-
versely, the “negative” symptoms refer to normal behaviors that are absent in patients with
schizophrenia and include social withdrawal, diminished emotional expression, and avolition
(Tandon et al., 2013). While cognitive deficits are a prominent feature of SZ psychopathol-
ogy, cognitive impairment is not a diagnostic criteria in the DSM-5, as it doesn’t sufficiently
distinguish schizophrenia from other psychotic disorders (Barch & Keefe, 2010).
Schizophrenia affects more than just mental health; factors such as personal care neglect
(Hayes et al., 2012), antipsychotic drug side effects such as weight gain (Sicras-Mainar et al.,
2008), comorbid addiction (Winklbaur et al., 2006) (as high as 90% of people with schizophrenia
are smokers) (Kelly & McCreadie, 2000), and increased lifetime risk of suicide (∼ 5%) (Hor &
Taylor, 2010) all contribute to the ∼15 years reduction in average lifespan seen in people with
SZ (Wahlbeck et al., 2011). Individuals with SZ are overrepresented among some of the most
marginalized groups in society including the homeless, unemployed, unmarried, incarcerated,
and chronically hospitalized (Carpenter & Koenig, 2008). As a result, SZ is often associated
with dependence, placing emotional and financial strain on families and substantial economic
burden on society at large (Lewis & Sweet, 2009). In order to improve the outlook for individuals
with SZ, new therapeutics need to be designed that adequately treat negative and cognitive
symptoms in addition to positive symptoms, while causing minimal adverse side-effects.
Schizophrenia has a strong genetic component, although its genetic underpinnings are
complex and poorly understood. Monozygotic twins have a concordance rate of approximately
50%; an over 70-fold enrichment above the .7% prevalence of SZ among the general population
(Kellendonk et al., 2009). Most of the genetic risk factors identified are common allelic variants
that individually confer only a small risk (Consortium, 2009). However, other studies have
identified structural variants such as copy number variants (CNVs)– either duplications or
deletions of large genomic regions– that confer a greater disease liability. The picture that has
emerged is that schizophrenia may be both a “common disease-common allele” and “common
disease-rare allele” genetic disorder (Arguello & Gogos, 2012; Walsh et al., 2014). However, a
major barrier to uncovering a genetic basis for the disorder is that “schizophrenia” may be an
umbrella term for a “diverse set of very rare genetic conditions that happen to share similar
symptoms” (Mitchell, 2012). While it’s unclear how many cases of schizophrenia rare structural
variants may account for, their high penetrance make them a good candidate for study in animal
models.
1.1.2 Evidence for PFC dysfunction in schizophrenia
Cognitive symptoms are increasingly recognized as a core symptom of SZ – impairments in
working memory (WM), attention, and executive function are present prior to the onset of
psychosis and are a mainstay throughout the course of the disease. Working memory has been
described as a “mental workspace” where items of information are held, shifted around, and
associated to other ideas and incoming information (Goldman-Rakic & Selemon, 1997). The
contents of WM are constantly updated and used to guide actions that accord with one’s internal
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goals across time. Efficient WM relies on the ability to buffer temporarily stored representations
against interference from either internal noise or external distractors (Manoach, 2003; Murray
et al., 2014). Impaired attention, the inability to filter out irrelevant stimuli, may contribute to
WM impairments by increasing such interference. Working memory is necessary for interpreting
chains of events in a rational way, and deficits in WM may contribute to the positive symptoms
of SZ such as delusions and hallucinations. Executive function is believed to play a supervisory
role over several cognitive domains in order to implement higher order processes such as response
inhibition, problem-solving, planning, and rule switching (Arguello & Gogos, 2006). Studies in
nonhuman primates and humans have identified the prefrontal cortex (PFC) as a critical node
in WM and executive function (Castner et al., 2004).
The processes of WM and executive function are important for accomplishing every day
life tasks. Unfortunately, the current medications used to treat SZ do not address the cognitive
impairments. Even the latest second-generation antipsychotic drugs are largely ineffective at
treating cognitive symptoms (Keefe et al., 2007), a harsh reality considering that cognitive
function is a key predictor for the long-term quality of life for people with SZ (Green et al., 2000).
Intriguingly, a period of relative cognitive decline from childhood to adulthood may predict the
psychotic phase of SZ (Kremen et al., 2010). Furthermore, cognitive impairment is commonly
seen in first degree relatives of individuals with SZ (Cannon et al., 2000; Myles-Worsley & Park,
2002; Snitz et al., 2006), suggesting that certain cognitive functions, and perhaps the brain
structures and circuits that subserve them, are highly heritable. Because cognitive impairment
is a strong determinant of the functional disability associated with schizophrenia, it’s become a
prime target for drug development (Carter et al., 2008). In order to remediate cognitive defects
in the future, it will be important to understand the nature of cognitive circuitry perturbations
associated with SZ.
In Dementia Praecox and Paraphrenia Dr. Kraepelin speculated that lesions of the
frontal cortex could produce the symptoms of dementia praecox (schizophrenia):
On various grounds it is easy to believe that the frontal cortex, which is specially
well developed in man, stands in closer relation to his higher intellectual abilities,
and these are the faculties which in our patients invariably suffer profound loss in
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contrast to memory and acquired capabilities. (1916, p. 219)
In line with Kraepelin’s intuitions, much of schizophrenia research today has focused
on the structure and function of the prefrontal cortex. As mentioned previously, patients with
SZ perform poorly in cognitive tasks that depend on efficient PFC processing, and functional
imaging studies find abnormal patterns of PFC activation in SZ patients during working memory
tasks (Callicott et al., 2000; Goldman-Rakic & Selemon, 1997; Manoach, 2003). Postmortem
studies have found various alterations in the prefrontal cortex, such as subtle changes in the
neuronal density, soma volume, and spine numbers (Lewis & Sweet, 2009). In addition, there
is a growing body of literature that suggests that SZ is associated with impaired GABAergic
transmission in the prefrontal cortex, which I will review below.
1.1.3 Evidence for altered excitation/inhibition balance in schizophrenia
Data from postmortem human studies suggests that schizophrenia pathology involves impair-
ments in GABAergic transmission. One of the most reproducible findings is a reduction of the
GABA synthetic enzyme GAD67 mRNA and protein levels in the dorsolateral prefrontal cortex
(DLPFC) of subjects with SZ. However, this finding is not specific to the prefrontal cortex and
is seen in other cortical regions (Curley et al., 2011; Gonzalez-Burgos et al., 2011). In addition,
∼50% of PV mRNA-positive neurons lacked detectable levels of GAD67 in schizophrenia rela-
tive to matched control subjects (Hashimoto et al., 2003). The expression of PV mRNA itself is
reduced in schizophrenia, while the total number of neurons that label for either PV mRNA or
protein are not (Tooney & Chahl, 2004; Woo et al., 1997). Taken together, these data suggest
that the number of PV+ INs aren’t reduced in patients with schizophrenia, but the function of
PV+ INs may be impaired.
Gamma-band oscillations, which reflect synchronized firing of principal neurons in the
30-80 Hz range, are induced during working memory tasks. In fact, gamma-band power in-
creases as a function of working memory load (Howard et al., 2003). Optogenetic studies have
demonstrated that gamma-band oscillations can be driven by selectively activating PV INs
(Cardin et al., 2009; Sohal et al., 2009). GABA α1 receptors are found at the postsynpase of
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PV basket cells, and a developmentally-related increase in GABAα1 expression correlates with
faster unitary IPSC decay times (Doischer et al., 2008). Furthermore, the emergence of these
faster IPSC decay times correlates with the emergence of gamma band oscillations (Doischer
et al., 2008). Patients with SZ have been shown to exhibit reduced DLPFC gamma-band power
during several phases of working memory tasks including the encoding, maintenance, and re-
trieval of stored information (Haenschel et al., 2009). In addition, patients with SZ exhibit
reduced frontal lobe gamma power during cognitive control tasks that test the subject’s ability
to manipulate the content of working memory in order to flexibly adapt thought and behavior
to achieve goals (Cho et al., 2006; Minzenberg et al., 2010). Furthermore, DLPFC GABA levels
measured by MRS have been shown to correlate with peak gamma power in DLPFC during a
working memory task (Chen et al., 2014). The picture that emerges is that patients with SZ
exhibit postmortem and electrophysiological signatures of impaired GABAergic transmission,
particularly as mediated by PV INs.
In addition to reduced markers of GABAergic transmission, it’s been observed that
patients with schizophrenia have reduced dendritic spine density in layer III DLPFC (Lewis &
Gonzalez-Burgos, 2008). One interpretation of the concomitant alterations in excitatory and
inhibitory circuit components, put forward by David Lewis and colleagues, is that an upstream
deficit in dendritic spines leads to compensatory downregulation of inhibition onto pyramidal
cells Fig1.1 (Lewis et al., 2012). However, the limitations of postmortem studies prevent the
disambiguation of primary impairments versus secondary compensatory changes. Nevertheless,
studies have demonstrated that reduced GABA transmission in mPFC is linked to alterations
in executive function. GABAA antagonism in rodents and nonhuman primates (Enomoto et al.,
2011; Sawaguchi et al., 1989), postnatal genetic ablation of NMDA receptors from corticolimbic
PV INs (Belforte et al., 2010; Carlen et al., 2012; Korotkova et al., 2010) or loss of PV INs in
the MAM G17 lesion model (Lodge et al., 2009) all produce cognitive deficits that resemble
those observed in schizophrenia and diminish gamma oscillations (Carlen et al., 2012; Lodge
et al., 2009).
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requires both better knowledge of the patterns of
connectivity within the DLPFC and more sensitive meth-
ods for assessing the functional integrity and compensa-
tions of these connections in the illness. In addition, the
use of appropriate animal models as proof-of-concept tests
of the hypothesized upstream versus downstream
relationships between cellular level alterations in schizo-
phrenia are essential. Such future advances will provide a
more informed substrate for designing rational interven-
tions to enhance cognitive function in people with
schizophrenia.
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Figure 3. Connectivity between pyramidal neurons (gray neurons) and parvalbumin-positive basket (PVBC) and chandelier (PVChC) cells in dorsolateral prefrontal cortex
(DLPFC) layer 3. Reciprocal connections formed by the local axon collaterals of pyramidal neurons provide recurrent excitation, whereas the excitatory inputs from pyramidal
neurons to PVBCs furnish feedback inhibition. These connections are critical for generating gamma band oscillations, and the strengths of these connections are adjusted to
maintain a normal excitation–inhibition (E/I) balance in the healthy brain (a). In schizophrenia (b), lower spine density in layer 3 pyramidal neurons is hypothesized to result in
lower network excitation, evoking a compensatory reduction in feedback inhibition of pyramidal neurons from PVBCs [less presynaptic glutamic acid decarboxylase (GAD)-67;
fewer postsynaptic GABAA a1 receptors) and increased depolarization of pyramidal neurons by PVChCs (less presynaptic GABA membrane transporter 1; more postsynaptic
GABAA a2 receptors). The resulting ‘reset’ of the E/I balance at a lower level of both excitation and inhibition renders the circuit less able to generate normal levels of gamma
band power, resulting in impaired cognition. Heat maps are reproduced, with permission, from [8].  (2006) Proceedings of the National Academy of Sciences.
Review Trends in Neurosciences January 2012, Vol. 35, No. 1
64
Figure 1.1: Post ortem human data suggests altered EI balance in schizophre ia. The top
panel shows the healthy situation, in which axon collaterals from pyramidal neurons (PNs) drive recurrent
excitation onto other pyramidal neurons and recruit feedback inhibition from connected parvalbumin
positive ba ket cells (PVBCs) in the cortex. The connections between PNs and PVBCs are critical
for ge erating gamma oscillations, and the relative strength of PN-PVBC and PVBC-PN connections
could be tuned to maintain a set E/I balance that can optimally generate gamma. In schizophrenia,
it is hypothesized that reduced spine density in layer III lowers network excitation, which results in
a compensatory downregulation of inhibito y mediators (see table). As a result, the new, lower E/I
set point reduces the network’s ability to generate gamma, particularly as cognitive load increases and
gamma power should normally ramp up. Reproduced from Lewis et. al 2012.
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1.1.4 Neurodevelopmental basis of schizophrenia
Today, schizophrenia is thought to be a disorder that is the consequence of abnormal brain
development. When schizophrenia was first described, it was believed to be a form of rapid
neurodegeneration but no evidence of gliosis in the brains of people with SZ exists to support
this claim (Woods, 1998). One piece of evidence for the neurodevelopmental basis of schizophre-
nia is the overlap of genetic risk factors for schizophrenia with childhood onset brain disorders
such as autism (Walsh et al., 2014). This overlap includes many genes that function in de-
velopmental processes such as neuronal proliferation, neuronal migration, axonal outgrowth,
myelination, and synapse development (Fatemi & Folsom, 2009). In addition, epidemiological
studies indicate that environmental stress during pre- and perinatal periods increases the risk
of developing schizophrenia (Cannon et al., 2002a). Prospective studies of “high risk” cohorts
have repeatedly found that the children of parents with schizophrenia exhibit delayed devel-
opmental milestones and perform more poorly on neuropsychological tests than other children
(Cannon et al., 2000; Davies, 2007; Erlenmeyer-Kimling et al., 2000; Kremen et al., 2010). A
critical period for the onset of schizophrenia appears to be adolescence, a time during which
glutamatergic synapses are pruned, myelination increases, and dopaminergic and inhibitory
circuits reach maturity (Insel, 2010; Jaaro-peled et al., 2009). A challenge for researchers is
to understand how schizophrenia lies relatively dormant for the first 1.5 to 3 decades before
the onset of psychosis when the disease becomes full-blown and rapidly debilitating (Lewis &
Lieberman, 2000). One idea is that the previously mentioned adolescence-related developmental
processes somehow unmask the early abnormalities in brain structure and connectivity. In this
way, schizophrenia might be thought of as a progressive neurodevelopmental disease (Cannon
et al., 2002b; Woods, 1998).
With no clear etiology, it has historically been difficult to study schizophrenia in model
organisms. Researchers have previously relied on psychoactive drugs that produce psychopathol-
ogy that is similar to what is seen in patients with SZ (e.g. PCP) (Arguello & Gogos, 2006) or
lesions made in early in development that produce phenotypic changes at adolescence that
are relevant to schizophrenia (Lodge & Grace, 2010). However, these models fail to cap-
ture the underlying cause of schizophrenia or recapitulate the diversity of impairments seen
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in schizophrenia. However, recent advances in psychiatric genetics have identified promising
genetic susceptibility factors for SZ that may hold the key to understanding how genes can
affect neurodevelopment, brain circuit function, and ultimately behavior. Below, I will describe
one such genetic risk factor examined in this thesis, Disrupted-in-Schizophrenia 1.
1.1.5 Identification of DISC1 as a psychiatric risk gene
The story of DISC1 begins, of all places, in a Scottish youth penitentiary. A cytogenetic survey
conducted by researchers identified an 18-year-old boy who carried a chromosomal translocation
between chromosome one and eleven ((1;11)(q42.1;q14.3)) (Jacobs et al., 1970) Fig1.2A. Work
over the next couple decades pieced together the Scottish pedigree (St. Clair et al., 1990)
and identified DISC1 (Disrupted-in-Schizophrenia-1) as the the open reading frame of a gene
that was disrupted by the translocation breakpoint (Millar et al., 2000) Fig1.2B. In addition
to DISC1, a noncoding RNA on the antisense strand to DISC1 (DISC2) is also disrupted
(Millar et al., 2000). Within the Scottish pedigree, the DISC1 translocation was reported
to cosegregate with schizophrenia and other psychiatric illness with a maximum logarithm of
the odds (LOD) score of 3.6 when the disease was restricted to schizophrenia and 7.1 when
relatives with recurrent major depression, bipolar disorder, and schizophrenia were included
(Blackwood et al., 2001). This is the highest LOD score ever reported for a genetic association
with schizophrenia, however, DISC1’s status as a “proven” risk factor for SZ has come under
fire (Sullivan, 2013), primarily because variation in DISC1 did not associate with psychiatric
disease in a GWAS mega-analysis (Consortium, 2013). However, variation in DISC1 has been
associated with schizophrenia in a separate Finnish cohort (Ekelund et al., 2004), and several
studies have reported that rare nonsynonymous mutations within DISC1 are enriched in SZ
cases compared to controls (Song et al., 2008). These findings lend credence to DISC1’s wider
relevance to schizophrenia. Finally, it should be noted that by design, genome-wide association
studies cannot detect rare events, and therefore GWAS isn’t a suitable validation for this
particular gene (Sullivan, 2013). Consequently, DISC1 may not be a prevalent genetic risk
factor for schizophrenia but biology supports the notion that it is a hub for signaling pathways
that contribute to schizophrenia pathology.
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It is known that specific cognitive impairment is a common feature of individuals with
schizophrenia. Intriguingly, cognitive functions such as short-term and long-term memory are
reliably impaired in non-schizophrenic relatives (Snitz et al., 2006) as a function of relatedness
(Cannon et al., 2000). In keeping with this, there is evidence that the DISC1 translocation
is associated with subclinical cognitive effects in the Scottish pedigree. t(1;11)(q42.1;q14.3)
translocation carriers display increased latency and reduced amplitude of the P300 event re-
lated potential (Blackwood et al., 2001), a measure of the speed and efficiency of information
processing that is consistently reduced in individuals with SZ (Begleiter & Porjesz, 1986). Re-
duced P300 amplitude has been correlated with reduced perfusion of the anterior cingulate
cortex (ACC) in patients with SZ and their relatives (Blackwood et al., 1999). In addition,
blood RNA levels of DISC1 and its interacting proteins partners were reported to correlate
with the performance of healthy controls in a PFC-dependent working memory task (Rampino
et al., 2014). So far there have been no postmortem studies of members of the Scottish pedi-
gree. Therefore, it’s unknown whether their brains exhibit patterns of changes (such as reduced
PV or GAD67 expression) that are consistent with observations from postmortem studies of
individuals with SZ. This may be a key point for determining the generalizability of DISC1
pathophysiological mechanisms to schizophrenia more generally. However, the evidence for
high heritability of cognitive phenotypes with the DISC1 translocation at least suggests that
cognitive impairment is a promising disease aspect to study within a DISC1 mouse model.
Common variants of the DISC1 gene have been associated with reduced gray matter
volume (particularly prefrontal and temporal regions) and increased ventricular volume in psy-
chiatric patients and controls (Brauns et al., 2011; Duff et al., 2013; Mata et al., 2010; Trost
et al., 2013) and were even reported to predict frontal lobe volume at birth (Knickmeyer et al.,
2013). Other studies have found that certain haplotypes that spanned DISC1 and the neigh-
boring TRAX gene were overrepresented among individuals with schizophrenia (Cannon et al.,
2005; Palo et al., 2007). Furthermore, DISC1 haplotypes have been associated with prefrontal
gray matter reductions and short- and longterm memory impairments (Cannon et al., 2005;
Carless et al., 2011; Hennah et al., 2005; Palo et al., 2007). Interestingly, reduced cortical
thickness in the ACC was associated with two DISC1 haplotypes (Carless et al., 2011), and
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the ACC is a region that has been observed to have reduced volume in people in individu-
als with schizophrenia and those who are at very high risk for developing it (Fornito et al.,
2009; Jung et al., 2011). These studies highlight the association between DISC1 function and
early brain development. Moreover, a common missense variant in the DISC1 gene, Ser704Cys
(rs821616) was found to be associated with reduced information transfer efficiency (Li et al.,
2013) and increased MD-PFC functional connectivity but reduced anatomical connectivity in
healthy controls (Liu et al., 2013). The authors argued that the increased functional connec-
tivity in the face of reduced anatomical connectivity could represent a compensatory effect
achieved in healthy controls but not individuals with schizophrenia, who exhibit both reduced
mediodorsal thalamus- prefrontal cortex functional and anatomical connectivity.
1.1.6 Cellular function of DISC1
DISC1 is a large, multifunctional scaffolding protein that facilitates the formation of protein
complexes. DISC1 has no known enzymatic activity itself, but is believed to regulate the ac-
tivity and localization of its protein binding partners. Over 200 protein interaction partners
have been identified by yeast two-hybrid studies (Camargo et al., 2007; Millar et al., 2003;
Morris et al., 2003) many of which have been biochemically confirmed (Kim et al., 2009; Morris
et al., 2003; Ozeki et al., 2003; Wang et al., 2010). Therefore, DISC1-related cognitive effects
likely arise from the dysregulation of a wide-array of protein-protein interactions across de-
velopment (Bradshaw & Porteous, 2012). Adding to the complexity, it’s been reported that
there are as many as 50 different DISC1 splice isoforms in the human brain that are dynam-
ically regulated across development (Nakata et al., 2009). The DISC1 gene is made up of 13
exons and its genetic structure is well-conserved, particularly within the C-terminal domain,
across multiple species including mice Fig1.2C (Chubb et al., 2008). The C-terminus encodes a
coiled-coiled domain predicted to facilitate DISC1 protein-protein interactions, and the t(1;11)
translocation is predicted interfere with C-terminus protein binding. Interestingly, many of
the protein-binding partners of DISC1 are also involved in neurodevelopmental processes, and
several (PDE4B, FEZ1, PCM1, NDE1 ) have been identified as independent risk factors for
major mental illness (Bradshaw & Porteous, 2012; Camargo et al., 2007; Chubb et al., 2008).
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Therefore, the high penetrance of the DISC1 translocation in the Scottish pedigree may be due
to the fact that DISC1 is a hub that lies in many pathways involved in neurodevelopment and
synaptic transmission (Porteous et al., 2014).
The temporal expression pattern of DISC1 mRNA highlights its role in brain devel-
opment as well as its potential role in postnatal brain maturation. DISC1 mRNA reaches
its peak expression embryonically at E13.5, underscoring its important role in neurodevelop-
mental processes like neurogenesis and migration (Schurov et al., 2004). A similar temporal
pattern of expression has been observed in human brain (Lipska et al., 2006). DISC1 is most
highly expressed in the dentate gyrus but is also expressed at high levels in the olfactory bulb,
cortex, and cerebellum (Schurov et al., 2004). In addition, DISC1 mRNA exhibits a second
peak of expression that corresponds to the onset of puberty in mice (P35) (Schurov et al.,
2004). Interestingly, one study that looked at inducible expression of a truncated human form
of DISC1 (hDISC1) found differential neurobehavioral effects of hDISC1 expression whether it
was restricted to the pre- or postnatal period (Ayhan et al., 2010).
DISC is not only expressed in the brain, but is found in other tissues such as placenta
and heart (Millar et al., 2000). DISC1 is found in multiple subcellular locations, including
mitochondria, cytoplastmic puncta/stress granules, the nucleus, centrosome, and actin filaments
(Brandon et al., 2005; James et al., 2004; Miyoshi et al., 2003; Morris et al., 2003; Ozeki et al.,
2003; Sawamura et al., 2005). Within neurons, DISC1 is found in dendritic spines, where it
colocalizes with the post-synaptic density (Hayashi-Takagi et al., 2010; Kirkpatrick et al., 2006)
and also at the presynapse (Wang et al., 2010). In addition to expression within excitatory
PNs, DISC1 has also been shown to be present in medial ganglionic eminence (MGE) derived
neurons, which include parvalbumin (PV) and somatostatin (SST) INs, (Steinecke et al., 2012)
and colocalizes with GAD67 (Meyer & Morris, 2008).
Animal models of DISC1 have mainly focused on two hypothesized consequences of
the t(1;11)(q42.1;q14.3) translocation: either loss-of-function knockdown or deletion models or
gain-of-function expression of a truncated dominant-negative form of DISC1 Fig1.2D. A non-
exhaustive list of DISC1 mouse models that have been generated include shRNA knockdown
mice (Hayashi-Takagi et al., 2010; Kamiya et al., 2005; Niwa et al., 2010) transgenic models
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that express a putative dominant-negative human DISC1 fragment (Hikida et al., 2007; Li
et al., 2007; Pletnikov et al., 2008), a transgenic mouse lacking exons 1-3 (Kuroda et al., 2011),
chemical mutagen-induced point mutants (Clapcote et al., 2007), and mice with a naturally
occurring micro deletion in exon 6 (Koike et al., 2006). Koike et al. found that C57Bl/6J
mice that were heterozygous for the 129 DISC1 variant performed significantly worse compared
to C57Bl/6J mice in a working memory task, suggesting that DISC1 is haploinsufficient with
respect to this PFC-dependent phenotype (Koike et al., 2006). This is interesting in relation
to the cognitive impairments seen in unaffected DISC1 translocation carriers and the fact that
DISC1 expression is approximately 50% lower in lymphoblastoid cell lines of t(1:11) transloca-
tion carriers Fig1.2D (Millar et al., 2005). In my thesis project, I studied a loss-of-function
model (unpublished) generated by Dr. Hannah Jaaro-Peled at Johns Hopkins University. In
this mouse, multiple genetic perturbations were introduced into the DISC1 locus including a
40-kb genomic deletion covering exons 1-3 of DISC1, in addition to the 25 bp deletion in exon
6, with the goal of eliminating as many DISC1 isoforms as possible.
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Schizophrenia
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Bipolar aective disorder
(1;11)(q42;q14) translocation
Figure 1.2: DISC1 chromosomal translocation: Scottish pedigree and gene structureA. A
karyotype of a propositus of the Scottish pedigree in the original Jacobs et al. paper. Arrows indicate
the translocation event. B. Scottish pedigree in which a balanced translocation between chromosome 1
and 11 was discovered. The breakpoint of this translocation was between exons 8 and 9 of a previously
unidentified gene DISC1. Note that the translocation segregates with a variety of major psychiatric
diagnoses within the family. C. Structure of the mouse ortholog of DISC1, a 13 exon gene with many
splice isoforms. Red dashed line indicates the breakpoint in the Scottish pedigree. D. Models of different
biological consequences of DISC1 translocation, including a truncated form of the protein, a fusion
protein, or the model of protein loss and haploinsufficiency. Figure A. from (Jacobs et al., 1970) B.
adopted from (Brandon & Sawa, 2011), Figure C. from (Duan et al., 2007), and Figure D. from (Brandon
& Sawa, 2011).
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Role for DISC1 in early brain development
DISC1 plays an important role in neuronal migration. DISC1 knockdown was first reported
to impair neurite outgrowth and delay neuronal migration, leading to fewer RNAi-transfected
neurons in the superficial layers of cortex at P14 (Kamiya et al., 2005). In addition, DISC1
RNAi-transfected neurons had less extensive dendritic arbors that appeared to be misoriented
with respect to the pial surface (Kamiya et al., 2005). The role of DISC1 in radial migration has
been replicated several times (Ishizuka et al., 2011; Kubo et al., 2010; Niwa et al., 2010; Singh
et al., 2010). In addition to cortical development, DISC1 regulates the migration and dendritic
arborization of newborn granule cells in the adult and neonatal hippoccampus (Duan et al.,
2007; Enomoto et al., 2009; Kim et al., 2009; Meyer & Morris, 2009; Tomita et al., 2011). In
utero DISC1 knockdown impaired the migration of granule cells in the hippocampus, similar to
the phenotype produced in the cortex. However, when DISC1 was knocked down in adult-born
granule cells it produced the opposite phenotype, such that neuronal migration was accelerated,
and granule cells exhibited precocious elaboration of dendritic arbors and synapse formation
(Duan et al., 2007). Given that dentate gyrus develops in an “outside-in” fashion as opposed
to the “inside-out” pattern of cortical layers during embryonic development, these results sug-
gests that DISC1 plays a role in relaying extracellular positional cues to intracellular migratory
machinery. Finally, DISC1 has also been shown to regulate the tangential migration of MGE-
derived interneurons (Lee et al., 2013b; Steinecke et al., 2012). The proposed mechanism of
DISC1’s control of migration is through its interactions with many microtubule-associated mo-
tor complex proteins such as NDE1, NDEL1, PCM1, and LIS1 (Camargo et al., 2007). DISC1’s
ability to anchor these proteins to the centrosome may organize the microtubule network for
interkinetic nuclear migration and radial migration.
In addition to regulating migration, DISC1 is important for two aspects of corticogen-
esis: proliferation of neuronal progenitors and the switch from proliferation to differentiation.
DISC1 knockdown in utero leads to reduced neural progenitor proliferation, resulting in early
cell cycle exit and ultimately fewer neurons (Mao et al., 2009). This is because when DISC1
is present, it binds to GSK3β to prevent it from phosphorylating β-catenin, which stabilizes
β-catenin and promotes neural proliferation. Furthermore, another DISC1 binding protein,
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Dixdc1, cooperates with DISC1 to regulate GSK3β. When Cdk5 phosphorylates Dixdc1, it
promotes the binding of the Dixdc1/DISC1 complex to Ndel1 (Singh et al., 2010), and DISC1
interaction with Ndel1 at the centrosome promotes the centrosome-microtubule dynamics re-
quired for neuronal migration (Kamiya et al., 2005). Finally, more recently it was shown that
phosphorylation of DISC1 itself reduces DISC1’s affinity for GSK3β and promotes its binding to
the dynein motor-related protein BBS1, highlighting another way in which DISC1 can regulate
the proliferation/migration transition (Ishizuka et al., 2011).
Related to DISC1’s function in microtubule dynamics in neuronal migration, DISC1 has
been shown to regulate neurite outgrowth, which involves microtubule dynamics and remodeling
of the actin cytoskeleton. In vitro expression of a truncated form of DISC1 resulted in fewer
outgrowths and shorter neurites (Hattori et al., 2010; Ozeki et al., 2003). Finally, DISC1
recruits its binding partner Ndel1 to the distal part of the axon where it forms a complex
with LIS1 and 14-3-3. DISC1 also binds Kinesin-1, apparently serving as a cargo receptor to
link the motor protein to the Ndel1-LIS1-14-3-3 complex. The knockdown of DISC1 inhibited
the accumulation of this complex and impaired axon elongation (Taya et al., 2007). DISC1’s
regulation of NDEL1’s subcellular localization for different developmental processes (migration
and axon elongation) highlights its role in regulating the function of its protein binding partners
either spatially (as in the case of NDEL1) or by inhibiting their enzymatic function (as in the
case of GSK3β).
DISC1 at the synapse
DISC1 has been shown to regulate spine size through its interaction with kalirin-7 a member
of the Rho-family of small G-proteins. DISC1 knockdown in vitro leads to a rapid increase in
the volume of spines and surface expression of GluR1 and increases the frequency of mEPSCs
onto DISC1 RNAi-transfected neurons. This process occurs due to kalirin-7’s increased access
to Rac1, a GDP/GTP exchange factor (GEF) that is known to regulate spine morphology and
plasticity in association with neuronal activity (Penzes & Jones, 2008). Interestingly, longterm
DISC1 knockdown in vivo causes spines to shrink, suggesting that Rac1 gain-of-function in-
creases spine growth in the short term but has deleterious effects on spines in the long term
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(Hayashi-Takagi et al., 2010). Another DISC1 interacting partner identified in the large yeast
2-hybrid screen (Camargo et al., 2007) that is found at the PSD is TNIK. DISC1 specifically
binds to the kinase domain of TNIK and prevents TNIK-mediated degradation of postsynaptic
proteins such as Glur1 and PSD95 (Wang et al., 2010). These findings suggest that DISC1 is
involved in regulating cytoskeletal dynamics that affect spine structure and postsynaptic com-
position primarily by titrating the activity levels of its protein binding partners. It is difficult to
anticipate how short-term knockdown experiments can translate to genomic models of DISC1
deficiency.
1.1.7 Summary of DISC1 mouse model behavioral findings
Despite the variation in the genetic models of DISC1 (discussed previously), there is a reas-
suring overlap in behavioral alterations. For example, frontal deficits that are characterized
by impairments in working memory (assessed by the DNMTP task) and latent inhibition are
present in all DISC1 models tested thus far (Brandon & Sawa, 2011). In contrast, spatial learn-
ing and memory are not perturbed. Meanwhile, the effects on social behavior and anxiety are
more mixed (Ayhan et al., 2010; Clapcote et al., 2007; Hikida et al., 2007; Ibi et al., 2010; Li
et al., 2007; Lipina et al., 2010; Pletnikov et al., 2008). In addition, many models show deficits
in pre-pulse inhibition (Clapcote et al., 2007; Hikida et al., 2007; Lipina et al., 2010; Niwa et al.,
2010) a measure of sensory-motor gating that is considered to be a reliable endophenotype in
schizophrenia (Amann et al., 2010).
In terms of brain structural changes, several studies have identified increased ventricular
volume/reduced cortical volume (Ayhan et al., 2010; Kvajo et al., 2008; Pletnikov et al., 2008)
and have noted reductions in dendritic spine number and/or dendritic complexity (Kvajo et al.,
2008; Lee et al., 2011; Li et al., 2007; Niwa et al., 2010; Pletnikov et al., 2008), and reduced
parvalbumin staining in the mPFC (Ayhan et al., 2010; Hikida et al., 2007; Ibi et al., 2010;
Lee et al., 2013a; Niwa et al., 2010; Shen et al., 2008). Increased ventricular volume/reduced
cortical volume is predicted from the described roles of DISC1 in regulating neural proliferation
and migration. Similarly, reductions in dendritic length may be ascribed to DISC1’s function
in neurite outgrowth, while spine reduction is consistent with the findings of Hayashi-Takagi
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et al. of DISC1’s regulation of kalirin-7 activity. In addition, the mispositioning of pyramidal
neurons due to delayed migration may affect their integration into the local cortical circuit and
therefore lead to reduced synapse formation and hence fewer spines. However, the robust finding
of reduced parvalbumin expression has no predicted cellular mechanism. The co-occurrence of
working memory impairment and reduced PV expression is of course intriguing in light of
human SZ data. While working memory impairments are observed in DISC1 t(1;11) carriers,
due to a lack of postmortem data it is not known whether they exhibit reduced markers of
inhibitory transmission in the PFC. Therefore, one possibility is that reduced PV expression
is a downstream consequence of a dysfunctional prefrontal cortical circuit caused by abnormal
neurodevelopment in DISC1 mouse models. While the mechanism underlying reduced PV
expression is likely complex and difficult to test, it is possible to examine the physiological
function of PV INs in DISC1 mouse models which may provide insight into the link between
DISC1 and working memory impairment.
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1.1.8 Cognitive impairment as an endophenotype of DISC1 genetic varia-
tion
As humans, we are highly social animals who are remarkably sensitive to small deviations
from “normal” behavior. To date, the diagnosis for SZ still relies solely on the recognition
of abnormal behaviors like hallucinations, delusions, or flat affect. An interesting question is
what type of variation the brain can buffer before disturbances reach the level of detectabil-
ity. For highly heritable psychiatric diseases, it’s predicted that family members may exhibit
subclinical symptoms that aren’t easily observable. This is essentially the concept of endophe-
notypes: that there are measurable phenotypes that lie beneath the surface of overt syndromic
behaviors. Endophenotypes lie somewhere between the cognitive and behavioral manifesta-
tions of, for instance, schizophrenia, and its elusive genetic and environmental underpinnings
(Gottesman & Gould, 2003). Studying specific endophenotypes may make the problem of
understanding complex diseases more tractable by narrowing the focus to establishing links
between genes and specific endophenotypes as opposed to genes and the disease as a whole.
In a similar formulation by Gordon and Moore, if we think of understanding the neurobiology
of schizophrenia as charting a course, there are many starting points (e.g. genetic or environ-
mental causes) and waypoints (pathophysiological theories, e.g. dopamine hypothesis) on the
path to understanding the symptoms of schizophrenia (Gordon & Moore, 2012). In the same
way, an endophenotype can be thought of as a waypoint on the course to understanding the
biology of schizophrenia. This framework has been adopted by the NIMH Research Domain
Criteria (RDoC) initiative whose stated goal is to understand the neurobiological mechanisms
that underly specific symptom domains, irrespective of clinical diagnosis (Cuthbert & Insel,
2013).
Gottesman and Gould laid out five criteria for identifying useful endophenotypes in
psychiatry: (1) the endophenotype should be associated with illness in the population; (2) it
should be heritable; (3) the endophenotype should be primarily state independent; (4) within
families, the endophenotype and the illness should co-segregate; and (5) it should be found
in nonaffected family members at a higher rate than in the general population (Gottesman &
Gould, 2003; Snitz et al., 2006). To extend these criteria to identifying useful mouse models of
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endophenotypes: (1) the gene of interest should be highly homologous (2) the endophenotype
should involve a brain region whose conserved function is relevant to cognitive or behavioral
symptoms that are seen in the disease population (Arguello & Gogos, 2012). I believe that the
cognitive impairments observed within the DISC1 pedigree (and in the larger SNP-association
studies) meet endophenotype criteria, particularly in the sense that DISC1 has been associ-
ated with working memory performance and PFC structure/activation in unaffected DISC1
translocation carriers and healthy controls who carry certain DISC1 polymorphisms. By mod-
eling DISC1 loss-of-function in the mouse, we can probe more deeply into the function of the
prefrontal cortex to understand how DISC1 genetic variation can lead to changes in cognitive
performance.
The goal of my thesis was to understand how disruption of the DISC1 gene might al-
ter cognitive-related circuitry that underlies the cognitive tasks that DISC1 has been shown
to modify. Rather than focusing on the impact of DISC1 loss-of-function at the molecular or
behavioral level, I focused my studies at the synaptic to circuit level in the prefrontal cortex.
In this way, I used the DISC1 heterozygous deletion mouse as a starting point to assess the
potential pathophysiological mechanisms that link DISC1 genetic variation to cognitive dys-
function. Given that there are a myriad of gene by environmental interactions that can give
rise to phenotypes that psychiatrists categorize as “schizophrenia”, the common feature of the
many “schizophrenias” should be altered function in brain areas that subserve the cognitive and
behavioral domains that contribute to the schizophrenia phenotype. I believe that uncovering
the points of convergence of brain circuit alterations across various genetic and environmental
animal models of SZ will shed light on the central pathophysiology of the disease.
As described in the second chapter of my thesis, within the mPFC, DISC1 deletion ap-
pears to primarily alter inhibitory transmission, particularly that mediated by the parvalbumin
(PV) interneurons. The observed reduction in action potential-independent inhibitory trans-
mission and increased GABA paired-pulse ration from PV INs led me to evaluate one current
hypothesis of schizophrenia pathology: altered excitation to inhibition (EI) balance. This the-
sis reports 1) the synaptic effects of DISC1 deletion on pyramidal and inhibitory interneuronal
populations in the prefrontal cortex 2) the characterization of a previously hypothesized direct
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projection from the mediodorsal thalamus to PV INs in the anterior cingulate cortex 3) altered
EI balance in the MD-ACC projection of DISC1 HET mice that is due to reduced feedforward
inhibition from PV INs.
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Figure 1.4: Summary “thesis roadmap” Based on a figure from (Gordon & Moore, 2012), I’ve
outlined my thesis project in terms of charting a course; with the starting point being the genetic risk
factor DISC1 and the endpoint being understanding the neurobiological basis of cognitive dysfunction in
carriers of DISC1 variants and, more broadly, individuals with schizophrenia. This thesis project focused
on DISC1 mediated changes of prefrontal cortical function as a potential pathophysiological cause of
cognitive dysfunction. Solid lines represent strong causal links, while dotted lines are still hypothetical.
In many studies, DISC1 has been shown to be important for neurodevelopment and many DISC1 animal
models show reduced parvalbumin in the prefrontal cortex. However, the neurodevelopmental mechanism
for this change is unknown. In addition, studies have shown that PV INs are the main interneuron subtype
that controls excitation to inhibition (EI) balance in the cortex. However, only preliminary evidence has
linked altered EI balance to cognitive dysfunction. In my thesis, I primarily worked at the waypoint, first
identifying a synaptic alteration at the PV-PN synapse in the mPFC of DISC1 mice and then working to
understand how this synaptic change could alter EI balance in a thalamocortical circuit that is relevant
to cognition and has been implicated in the pathophysiology of schizophrenia.
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1.2 Summary of performed experiments
I first performed whole-cell patch clamp electrophysiological recordings from superficial pyra-
midal neurons in the dorsal portion (ACC and PL region) of the mPFC in adult mice. I
recorded miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs)
that arise from action potential independent fusion of single synaptic vesicles. By comparing
the mEPSC and mIPSC measurements onto pyramidal neurons, I was able to survey the net
inhibitory vs. excitatory input onto pyramidal neurons in mice heterozygous for DISC1 dele-
tion and their wildtype littermates. I found that mEPSCs were consistent across genotypes,
while the frequency of mIPSCs was significantly reduced in DISC1 HET mice. Meanwhile,
mEPSC recordings onto PV and SST INs revealed that excitatory transmission onto INs was
either normal or enhanced in the DISC1 HET background. Together, these data suggested that
presynaptic GABA release is impaired in DISC1 HET mice. To further characterize GABA
release from presynaptic inhibitory neurons, I selectively expressed Cre-dependent ChR2 in
the two major populations on inhibitory INs in the mPFC, PV and SST INs. I measured the
paired-pulse ratio (PPR) of PV+ or SST+ ChR2-evoked IPSCs in DISC1 HET or WT mice and
found that the PPR of PV-mediated but not SST-mediated IPSCs was significantly increased
in DISC1 HET mice.
In the second set of experiments, I characterized a brain circuit that strongly recruits PV
INs. Cre-dependent monosynaptic rabies tracing revealed that a dense population of neurons in
the mediodorsal nucleus of the thalamus (MD) project to PV INs in the mPFC. Through in vitro
optogenetic electrophysiology experiments, I confirmed that PNs and PV INs receive monosy-
naptic excitatory input from the MD and that MD stimulation drives disynaptic inhibitory
currents onto layer III PNs. In addition, I confirmed that MD-driven IPSCs were mediated by
PV INs. I performed a combined in vitro optogenetic stimulation and silencing experiments
to suppress firing in either PV or SST INs while simultaneously activating MD fibers. I found
that silencing PV INs significantly reduced, and in some cases abolished, feedforward inhibition
in the MD-mPFC pathway. Meanwhile, SST silencing never reduced MD-evoked IPSCs and in
fact significantly enhanced feedforward IPSCs. Our PV inactivation experiments support the
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idea that PV INs mediate feedforward inhibition, and effectively shunt excitatory input onto
layer III pyramidal neurons, thus narrowing the window of time over which excitatory currents
can be integrated. Finally, I measured the functional output of the MD-mPFC feedforward
inhibitory circuit in DISC1 HET mice. Given that I observed increased GABA PPR from PV
INs in DISC1 HET, and PV interneurons were then determined to be the major mediators of
MD-driven inhibition, I conclude that PV mediated GABA release is impaired in the MD-dACC
feedforward circuit of DISC1 HET mice.
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Chapter 2
Cell type-specific effects of reduced
DISC1 expression
2.1 Introduction
The prefrontal cortex, particularly the DLPFC, has been a prime locus of schizophrenia (SZ) re-
lated pathology that is believed to contribute to cognitive impairment. While the rodent mPFC
is not as complex as the primate PFC, it still retains many of the functional and anatomical
characteristics. Therefore, the study of homologous prefrontal regions within experimentally-
tractable rodents are an important tool for understanding SZ-related cognitive impairment.
The most widely accepted definition of the rodent PFC today is that it is the projection zone of
the mediodorsal nucleus of the thalamus (MD) (Divac, 1993; Heidbreder & Groenewegen, 2003;
Rose & Woolsey, 1948). By this definition, the prefrontal cortex involves all of the cortex of
the dorsolateral, orbital and medial frontal lobe rostral to the precentral motor cortex (O¨ngu¨r
& Price, 2000). However, because the rodent frontal cortex completely lacks a granular zone,
it is difficult to determine whether rodents have a homolog of the primate DLPFC. The main
part of the prefrontal cortex lies along the medial wall, anterior and dorsal to the knee of the
corpus callosum. The mPFC can be further divided into four cytoarchitectonically distinct
areas dorsal to ventral: the medial precentral area (PrCm, also called M2), the anterior cingu-
late cortex (ACC), the prelimbic cortex (PrL), and the infralimbic cortex (IL) (Heidbreder &
Groenewegen, 2003). Heidbreder and Groenewegen proposed that the mPFC could be divided
into dorsal-ventral streams, whereby the dorsal mPFC areas have distinct connections with
sensorimotor and association areas that ventral mPFC lacks, while ventral mPFC has more in-
terconnections with temporal and limbic structures. These patterns suggest that dorsal mPFC
areas are more involved in the planning of behavioral sequences, while the ventral mPFC may
be more involved in integrating internal state with environmental cues to guide behavior (Heid-
breder & Groenewegen, 2003). All of the mPFC structures are likely to contribute to executive
function, which involves sensory integration, the sensing of internal states, motor planning, and
action evaluation.
As mentioned previously, the rodent prefrontal cortex is agranular and thus lacks a layer
IV. Therefore the thalamic input to mPFC terminates within layer III. Pyramidal neurons
within layers II/III of the cortex are reciprocally connected with neurons in other cortical
areas, while deeper layers projects to subcortical targets. Projection neurons in layer V can
subdivided into intratelencephalic (IT) neurons that project to the cortex and striatum, and
pyramidal tract (PT) neurons that are restricted to layer Vb and project to the brainstem and
spinal cord (Shepherd, 2013). Finally, layer VI contains corticothalamic projection neurons.
The majority (70-80%) of the neurons in the cortex are glutamatergic (DeFelipe & Farinas,
1992) while the remaining (20-30%) are inhibitory interneurons (Markram et al., 2004). Of
these inhibitory interneurons, almost all are accounted for by three markers: parvalbumin,
somatostatin, and 5HT3a (Rudy et al., 2010). The two major interneuron populations (PV
and SST) are exclusively derived from the medial ganglionic eminence (Xu et al., 2004).
PV and SST INs have distinct properties that confer them with different modes of
inhibitory control in the cortex. Fast-spiking PV INs include basket and chandelier cells that
target the soma/basilar dendrites and axon initial segment, respectively. Chandelier cells are
thus poised to gate action potential generation (Howard et al., 2005), and apparently promote or
inhibit spiking in a state-dependent manner (Woodruff et al., 2011). PV INs have been shown to
be important for shaping spike timing and the dynamic range of cortical activity (Cardin et al.,
2009; Cruikshank et al., 2007; Gabernet et al., 2005; Pouille & Scanziani, 2001; Sohal et al.,
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2009). In addition, they’ve been shown to mediate gain control in the cortex (Atallah et al.,
2012). Postmortem SZ studies have found consistent alterations to PV INs, such as reduced PV
expression, and selective reduction of GAD67 in PV INs compared to other INs (Curley et al.,
2011; Hashimoto et al., 2003; Tooney & Chahl, 2004; Woo et al., 1997). Meanwhile, SST INs
have been typically associated with Martinotti cells, GABAergic INs whose ascending axons
ramify in layer I and spread horizontally to target distal dendrites of pyramidal neurons (Rudy
et al., 2010). Recently, SST INs have also been shown to inhibit PV INs in thalamorecipient
layer IV (Xu et al., 2013). SST INs display heterogeneous firing patterns and can be classified
as regular or burst spiking (Kawaguchi, 1996). Strong facilitating excitatory inputs onto SST
INs can recruit strong feedback inhibition (Silberberg & Markram, 2007), and SST IN targeting
of distal dendrites places them in a position to influence dendritic integration (Gentet et al.,
2012). In postmortem SZ studies, transcriptome analysis found that SST mRNA levels were
lower in SZ vs. controls (Hashimoto et al., 2008).
To date, there have been no studies in DISC1 animal models assessing the synaptic
properties of inhibitory IN populations. Because a variety of DISC1 animal models exhibit
impaired working memory and reduced PV expression, we hypothesized that there is an mPFC
circuit dysfunction in DISC1 loss-of-function and dominant negative models. In order to begin
to understand how mPFC circuit function might be impaired in the DISC1 locus impairment
(LI) mouse, we first assessed spontaneous transmission onto the major players of the mPFC:
pyramidal neurons (PNs), parvalbumin (PV) interneurons, and somatostatin (SST) interneu-
rons. The results of our ‘mini survey’ led us to interrogate the function of PV INs in more
depth. In this chapter we report the effects of DISC1 genomic deletion and cell type-specific
knockdown on mEPSC and mIPSC transmission in the mPFC. Furthermore, we assess the effect
of DISC1 genomic deletion on short-term plasticity at the PV-PN and SST-PN synapses.
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2.2 Methods
2.2.1 Animals
All mice were bred and maintained in on-campus animal facilities, and all experimental pro-
cedures involving animals were approved by the Institute Animal Care and Use Committees
of Cold Spring Harbor Laboratory and carried out in accordance with US National Institutes
of Health standard. Mice were group-housed under a 12-h light-dark cycle (7 a.m. to 7 p.m.
light) with ad libitum access to standard pellet food and water.
In order to study the effects of reduced DISC1 protein expression on prefrontal cortical
circuit function, we utilized an unpublished DISC1 “locus impairment” mouse model generated
by Dr. Hanna Jaaro-Peled in the lab of Dr. Akira Sawa at Johns Hopkins University. This
mouse line has a 40 kb deletion that spans exons 1 through 3 of murine DISC1, together with
a 250 bp microdeletion in exon 6. It was demonstrated to deplete the major full-length 100 kD
isoform of DISC1, and was designed to eliminate as many DISC1 splice isoforms as possible.
Briefly, a BAC-based genomic library generated from C57Bl/6J-129SvEv-hybrid embryonic
stem cell lines was screened to identify a DISC1-containing clone. This clone was subsequently
modified by a RecA-mediated recombination strategy so that the 40 kb genomic region was
replaced with a neomycin selection cassette. Embyronic stem cell clones that were successfully
targeted with the modified BAC were injected into C57Bl/6J blastocysts, and generations of
backcrossing into the C57Bl/6J line standardized the genetic background. In our studies, DISC1
mice that retained 1 functional copy of DISC1 were used because homozygous knockout mice
exhibit obvious physical defects such as runting and motor impairments. Furthermore, loss of
a single functional copy of DISC1 more closely mimics the predicted effect of the chromosomal
translocation observed in the Scottish pedigree.
In order to assess the effects of reduced DISC1 protein expression on inhibitory interneu-
ron subtypes within the mPFC, we crossed the DISC1 HET mouse line onto the SST-IRES-Cre
and PV-IRES-Cre transgenic reporter lines. These transgenic reporter lines drive expression of
Cre-recombinase downstream of the somatostatin (Taniguchi et al., 2011) or parvalbumin pro-
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moter, respectively (Hippenmeyer et al., 2005). Cell type-restricted Cre-recombinase expression
was utilized in my project in two ways: Cre recombinase mediated the excision of a loxP site
flanked STOP codon (lox-STOP-lox) upstream of a sequence of interest packaged in virus or,
alternatively, when crossed onto the Ai14 reporter mouse line mediated the excision of a lox-
STOP-lox sequence upstream of the TdTomato red fluorescent protein (Madisen et al., 2010).
These two strategies allowed us to manipulate or visualize distinct populations of inhibitory
interneurons in the mPFC within the context of the DISC1 locus impairment.
2.2.2 Stereotaxic surgery
Standard surgical procedures were followed. Mice were anesthetized with ketamine (100 mg/kg
body weight) supplemented with xylazine (10 mg/kg body weight), and secured in a stereotaxic
frame using serrated non-rupture ear bars. The injection frame was linked to a digital mouse
brain atlas to define injection coordinates and guide the injection pipette to the target location
(Leica ANGLE TWO, MyNeuroLab.com). 1 uL of Cre-dependent DISC1 shRNA or scrambled
hairpin virus was delivered into the mPFC (A/P 1.94 mm; M/L .34 mm; D/V 2.0 mm ver-
tical from the cortical surface) through a small burr hole in the skull (1-2 mm2) via pressure
application (5-12 psi, Picrospritzer III, General Valve). Mice were returned to their home cage
and placed on a heating pad where they were allowed to recover for 12-24 hours. Neosporin
was applied to the sutured skin and mice were provided recovery diet gel (ClearH2O). Mice
were monitored once per day for activity level and surgical site appearance for at least three
days post-surgery. For DISC1 shRNA experiments, DISC1 HET and WT animals crossed to
SST-IRES-Cre or PV-IRES-Cre mice were injected at P45 and recorded at P64-76. For GABA
PPR experiments, Cre+ DISC1 HET and WT littermates were injected unilaterally with 0.5
uL of AAV-DIO-ChR2(H134R)-GFP at P54 and recorded approximately 2 weeks later.
2.2.3 Viral constructs
For DISC1 knockdown experiments, we utilized a shRNA sequence that has been extensively
characterized (Ishizuka et al., 2011; Kamiya et al., 2005): the 5’-GGCAAACACTGTGAAGTGC-
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3’ sequence was packaged into an AAV construct that contains a floxed STOP codon cassette
that enables Cre-dependent shRNA and GFP expression (Kuhlman & Huang, 2008). The con-
trol shRNA construct was also Cre-dependent but expressed a scrambled target sequence with-
out homology to any known messenger RNA as well as GFP downstream of the floxed STOP
codon. The lox-STOP-lox DISC1 shRNA AAV and lox-STOP-lox scrambled shRNA-AAV were
generously gifted by the Sawa lab at Johns Hopkins University. Dr. Saurav Seshadri of the Sawa
lab performed immunohistochemistry experiments to validate the specificity of shRNA/GFP
expression and DISC1 knockdown in vivo (Seshadri et al. 2014, submitted).
2.2.4 Electrophysiological recordings of miniature events
Mice were anesthetized with isoflurane and decapitated, and their brains were quickly removed
and chilled in ice-cold dissection buffer. (110.0 mM choline chloride, 25.0 mM NaHCO3, 1.25
mM NaH2PO4, 2.5 mM KCl, 0.5 mM CaCl2, 7.0 mM MgCl2, 25.0 mM glucose, 11.6 mM
ascorbic acid and 3.1mM pyruvic acid, gassed with 95% O2 and 5% CO2). Coronal sections
containing mPFC were cut at 300 uM thickness in dissection buffer, using a HM650 vibrating
microtome (MICROM International GmbH), and transferred to a storage chamber containing
ACSF (118 mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO3, 1 mM NaH2PO4, 20 mM glucose,
2 mM MgCl2 and 2 mM CaCl2, at 34 C, pH 7.4, gassed with 95% O2 and 5% CO2) at
34C for 30 min before it was transferred to room temperature (RT, 20-24C) and allowed to
recover for an additional 30 min. Slices were then transferred to a recording chamber where
they were constantly perfused with ACSF. All recordings were done without heating, at room
temperature.
For pyramidal neuron miniature EPSC/IPSC recording experiments male and female
DISC1 HET and WT littermates were recorded at age P70-P80. For SST and PV miniature
EPSC/IPSC recording experiments, DISC1 HET or WT SST-IRES-Cre; Ai14 or PV-IRES-
Cre; Ai14 mice were recorded at P54-P64. Whole cell voltage clamp recordings were obtained
from layer II/III pyramidal neurons in the dorsal portion of the mPFC (including ACC and
PrL cortex) in DISC1 HET and WT littermates (both male and female) aged P70-P80. The
PrL region was identified based on landmarks (forceps minor of the corpus callosum) and
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by measuring the distance from the midline and cortical surface. Borosilicate pipettes (3-5
MΩ) were filled with internal solution containing 115 mM cesium methanesulphonate, 20 mM
CsCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2-ATP, 0.4 mM Na3GTP, 10 mM sodium
phosphocreatine. Miniature excitatory post synaptic currents (mEPSCs) were recorded at -70
mV in the presence of 1 uM tetrodotoxin (TTX) and 100 uM picrotoxin (PTX). For mEPSC
experiments, ACSF contained 2 mM CaCl2 and 2 mM MgCl2. Miniature inhibitory post
synaptic currents (mIPSCs) were recorded at 0 mV in the presence of 1 uM TTX, 100 uM DL-
AP5, and 10 uM CNQX, and ACSF contained 2 mM CaCl2 and 1 mM MgCl2. Recording data
was obtained using Multiclamp 700B amplifiers (Molecular Devices), and the liquid junction
potential was not corrected for. Miniature recording data was collected in gap-free mode in
pClamp 10 (Molecular Devices) for 10 minutes at room temperature.
2.2.5 Electrophysiological recording of GABA PPR
Two weeks post-injection, mice were sacrificed and acute slices were prepared as previously
described. IPSCs were evoked by activating ChR2+ PV or SST INs by delivering a 1 ms blue
light pulse through the 60x objective centered on the PN being recorded. IPSCs onto layer III
pyramidal neurons were recorded at 0 mV holding potential in the presence of 10 uM CNQX
and 100 uM AP-5. Light pulses were delivered at intervals of 50, 100, and 150 ms with ∼30
individual trials recorded at each interval. Trials were averaged and the paired-pulse ratio
calculated as the peak amplitude of the second evoked IPSC divided by the peak amplitude
of the first evoked IPSC. In many cases, the first IPSC did not fully decay to baseline before
the onset of the second IPSC. In these cases, the baseline of the second IPSC was corrected
before the peak was measured. In order to compare the kinetics of the PV vs. SST IN-evoked
IPSCs, averaged sweeps collected at the 150 ms interval were normalized, and the decay time
constant and half-width were measured using automated procedures in the AxoGraph X 1.5.4
software.
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2.2.6 Data analysis and statistics
For pyramidal neuron mEPSC data, 250 events were analyzed per cell and for mIPSC data,
300 events were analyzed per cell using Mini Analysis Program (Synaptosoft). For PV mEPSC
data, 500 events were analyzed per cell, and for SST mEPSC data, 350 events were analyzed.
Detection parameters for synaptic events, as well as the window across which detected events
were reviewed, were maintained across files in order to improve intra-rater reliability. All sta-
tistical tests were performed in the Origin9.0 software (OriginLab, Northampton, MA) and
GraphPad Prism version 6.0 (GraphPad Software, San Diego, CA). All data were tested for
normality using the D’Agostino-Pearson omnibus normality test to guide the selection of para-
metric or non-parametric statistical tests. For parametric data, a two-tailed t-test or two-way
ANOVA was used, and for non-parametric data a two-tailed Mann-Whitney inverted U test
or Kruskall-Wallis ANOVA test was used with a post-hoc Mann-Whitney test with Bonferroni
correction.
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2.3 Results
2.3.1 Changes in spontaneous inhibitory transmission onto pyramidal neu-
rons
As a means to survey whether DISC1 genomic deletion affects synaptic function in the local
mPFC circuit, I first recorded action potential-independent excitatory and inhibitory transmis-
sion onto layer II/III pyramidal neurons in adult (>P70) DISC1 HET and WT mice. Miniature
synaptic currents reflect the spontaneous exocytosis of neurotransmitter-filled vesicles. There
was no difference in mEPSC frequency or amplitude onto layer II/III pyramidal neurons in
DISC1 HET mice compared to WT Fig2.1A1-4 (p= .17, Mann-Whitney; p= .86, two-tailed
t-test n= 23, 20 N= 4, 5). While the amplitude of mIPSCs was not different between genotypes
(p= .51, Mann-Whitney) Fig2.1B1-2 the frequency of mIPSCs was significantly reduced in
the DISC1 HET mice compared to WT Fig2.1B3-4 (**p<.01, Mann-Whitney n= 27, 29 N=
6, 5) suggesting a presynaptic impairment.
2.3.2 Age-dependent changes in spontaneous inhibitory transmission in DISC1
HET and WT mice
Given that there is evidence that inhibitory transmission matures over the course of postnatal
development (Hensch, 2005), I tested whether the reduced mIPSC frequency observed in adult
DISC1 HET mice was present in preweanling DISC1 HET mice. I recorded mIPSCs onto
layer II/III PNs in P12-P20 DISC1 HET mice and their WT littermates. Kruskal Wallis
ANOVA revealed a significant effect of age on amplitude for both genotypes Fig2.1E (χ(1)
= 14, ***p<0.001; χ(1) = 15, ****p<0.0001). In addition, WT mice exhibited a significant
of age on frequency (χ(1) = 4, *p<0.05, Kruskal-Wallis ANOVA) while DISC1 HET mice did
not Fig2.1 F (χ(1) = 0.29, p = 0.59, Kruskal-Wallis ANOVA). A post-hoc Mann-Whitney
test with a Bonferroni correction showed that mIPSC frequency was significantly lower in
DISC1 HET compared to WT mice in the juvenile group (*p<0.05). These results suggest
that DISC1 HET mice undergo the normal process of strengthening inhibitory synapses during
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adolescence, but presynaptic inhibitory neurons fail to exhibit an accompanying age-related
increase in release probability or inhibitory synapse number. DISC1 HET mice seem to “start
out” with lower spontaneous inhibitory transmission compared to WT mice and do not catch
up by adulthood.
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Figure 2.1: Spontaneous excitatory and inhibitory transmission onto layer II/III PNs in
mPFC. A. Genomic deletion of DISC1 did not affect mEPSC frequency or amplitude in adult (P70)
DISC1 HET mice compared to wild type littermates. Genomic deletion of DISC1 significantly reduced
the frequency of mIPSCs onto layer III PNs but did not affect mIPSC amplitude. C. Representative
traces of mIPSCs recorded in WT and DISC1 HET mice; scale bar = 500 ms, 20 pA. D. Cumulative
probability distributions for mIPSC amplitude and inter-event interval. E. Both WT and HET mice show
a significant effect of age on mIPSC amplitude. F. WT mice exhibited a significant interaction between
age and mIPSC frequency while DISC1 HET mice did not. A post-hoc Mann-Whitney test with a
Bonferroni correction showed that mIPSC frequency was significantly lower in DISC1 HET compared
to WT mice in the P<20 age group (***p<0.001 **p<0.01 * <0.05 Mann-Whitney and Kruskal-Wallis
ANOVA test used.
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2.3.3 Postnatal DISC1 knockdown
In addition to assessing the effect of genomic DISC1 deletion, I wanted to test the effect of
cell-type restricted postnatal knockdown of DISC1. DISC1 mRNA expression peaks during
E13.5, consistent with its important role in neuronal differentiation and migration (Brandon
& Sawa, 2011; Brandon et al., 2009). Intriguingly, there is a second dramatic increase in
DISC1 expression that occurs around the onset of puberty (P35) (Schurov et al., 2004). The
significance of this second peak is unknown, but DISC1 has previously been shown to function
at the postsynaptic density (Hayashi-Takagi et al., 2010; Wang et al., 2010). It’s therefore
possible that the later DISC1 expression peak reflects a pool of synaptic DISC1 protein, and
could be important for puberty-related synaptic remodeling (Selemon, 2013). To assess the
significance of pubertal DISC1 expression, I injected Cre-dependent DISC1 shRNA lentivirus
into DISC1 HET and WT SOM-IRES-Cre or PV-IRES-Cre mice at P40 and recorded 2 weeks
later.
2.3.4 Changes in spontaneous transmission onto PV+ interneurons
PV-restricted DISC1 knockdown significantly increased the frequency of mEPSCs onto PV+
interneurons in the mPFC compared to scrambled hairpin (p>.05, Mann-Whitney test), while
it did not affect mEPSC amplitude Fig2.2A,B (*p<.05, Mann-Whitney test) (p = .84, Mann-
Whitney). Meanwhile, there was no significant difference in the frequency or amplitude of
mEPSCs onto PV+ INs in adult DISC1 HET vs. DISC1 WT mice Fig2.2C,D (p= .91, two-
tailed t-test, p= .08, two-tailed t-test).
43
CT
RL
 sh
RN
A
DI
SC
1 s
hR
NA
0
5
10
15
20
Fr
eq
ue
nc
y 
(H
z)
WT HE
T
0
5
10
15
20
Fr
eq
ue
nc
y 
(H
z)
CT
RL
 sh
rN
A
DI
SC
1 s
hR
NA
0
10
20
30
40
A
m
pl
itu
de
 (p
A
)
WT HE
T
0
10
20
30
40
A
m
pl
itu
de
 (p
A
)
0.0
0.5
1.0
Interval (s)
C
um
ul
at
iv
e 
pr
ob
ab
ili
ty
DISC1 shRNA
CTRL shRNA
1 2
1 2
0.0
0.5
1.0
Interval (s)
C
um
ul
at
iv
e 
pr
ob
ab
ili
ty
DISC1 +/-
Wildtype
1 2
10 20 30 40
0.0
0.5
1.0
10
Amplitude (pA)
C
um
ul
at
iv
e 
pr
ob
ab
ili
ty
0.0
0.5
1.0
10 20 30 40
C
um
ul
at
iv
e 
pr
ob
ab
ili
ty
Amplitude (pA)
CTRL shRNA
DISC1 shRNA
Wildtype
DISC1 +/-
*
A. B.
C. D.
E. F.
Figure 2.2: Spontaneous excitatory transmission onto PV+ INs in mPFC. A. PV+ IN restricted
DISC1 knockdown significantly increased mEPSC frequency (p<.05, Mann-Whitney) but did not affect
mEPSC amplitude compared to scrambled hairpin controls (n= 27, 20 N= 5, 4). B. mEPSCs were
comparable across WT and DISC1HET genotypes (n= 20, 23 N= 4, 4). C.D. Cumulative probability
distributions for inter-event interval and amplitude. E.,F. Representative mEPSC traces from knockdown
and genomic deletion experiments; scale bar = 500 ms, 10 pA.
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2.3.5 Changes in spontaneous transmission onto SST+ interneurons
SST-restricted DISC1 knockdown significantly increased the amplitude of mEPSCs onto SST+
INs in mPFC compared to scrambled control Fig2.3A,B (**p<.01, two-tailed t-test) while it
did not affect mEPSC frequency (p= .60, Mann-Whitney). Interestingly, increased mEPSC
amplitude onto SST+ INs was also observed when comparing DISC1 HET mice to WT litter-
mates Fig2.3C,D (**p<.01, Mann-Whitney), with no effect on mEPSC frequency (p= .125,
Mann-Whitney).
To determine if DISC1 knockdown also altered inhibitory transmission onto SST+ in-
terneurons, I recorded mIPSCs onto SST+ INs infected with DISC1 shRNA or scrambled
control shRNA. I found that there was a trend towards increased mIPSC amplitude onto SST+
INs following DISC1 knockdown compared to control but that amplitude was unaffected (p=
.068 p= .169, two-tailed t-test Fig2.4.
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Figure 2.3: Spontaneous excitatory transmission onto SST+ INs in mPFC. A. SST+ IN re-
stricted DISC1 knockdown significantly increased mEPSC amplitude (**p<.01, Mann-Whitney) but
did not affect mEPSC frequency compared to scrambled hairpin controls (p (n= 15, 19 N= 4, 3). B.
mEPSC amplitude was also increased in DISC1 HET mice compared to WT littermates (**p<.01, (n=
13, 27 N= 3, 4). C.D. Cumulative probability distributions for inter-event interval and amplitude. E. F.
Representative mEPSC traces from knockdown and genomic deletion experiments; scale bar = 1 s, 10
pA.
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Figure 2.4: Spontaneous inhibitory transmission onto SST+ INs in mPFC. SST+ IN restricted DISC1
knockdown did not significantly alter mIPSC amplitude or frequency onto SST+ INs but there was a
trend towards increased amplitude (p= .068, two-tailed t-test; p= .169 n= 12, 9 N= 3, 2)
2.3.6 Altered short-term plasticity at PV-PN synapse in DISC1 HET mice.
The observed decrease in mIPSC frequency onto layer II/III PNs in DISC1 HET mice compared
to WT mice is compatible with a reduction of inhibitory synapse numbers onto pyramidal
neurons, a reduction in presynaptic GABA release probability, or both. Because mPSCs reflect
vesicular release from an unidentified mixture of presynaptic neurons, we first sought to test
the GABA release properties in two genetically-defined inhibitory interneuron subtypes: PV+
and SST+ inhibitory interneurons. Together, PV and SST interneuron subtypes comprise ∼
70% of inhibitory interneurons in the (somatosensory) cortex (Rudy et al., 2010).
We first measured the PPR of IPSCs evoked from Chr2+ PV INs onto layer III PNs
in mPFC Fig2.5A,B. Repeated measures two-way ANOVA was performed for cells that were
recorded at the 50, 100, and 150 ms interstimulus intervals (3 HET cells were missing 150 ms
data). There was a significant effect of genotype and interval on PPR (genotype, F(2, 42)=
3.915 *p<0.05; interval, F(2, 42)= 6.772 **p<0.01) and the interaction of the two (F(21, 42)=
3.915 *p<0.05). Post hoc Sidak’s multiple comparisons test revealed that PPR was significantly
higher in DISC1 HET mice than WT mice at the 50 (***p<0.001) and 100 (*p<0.05) inter-
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stimulus intervals Fig2.5B-C.These results were surprising given that short-term depression is
considered to be characteristic of PV-expressing synapses (Caillard et al., 2000; Hefft & Jonas,
2005; Owen et al., 2013). It is likely that the PV-IRES-Cre line captures a heterogenous popu-
lation of interneurons, and therefore GABA release may be affected in a subset of PV-IRES-Cre
cells under conditions of reduced DISC1 expression.
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Figure 2.5: PV-evoked IPSC PPR is increased in DISC1 HET mice. A. Recording configuration:
1 ms blue light pulses were delivered at 50, 100, and 150 ms intervals to evoke IPSCs from ChR2+ PV
interneurons onto layer II/III PNs in mPFC. C. Representative traces from WT and DISC1 HET mice
at 50, 100, and 150 ms intervals. Black lines represent single trials, averaged traces in gray. C. DISC1
HET mice exhibited significantly higher evoked IPSC PPR at 50 ms and 100 ms intervals (**p<0.01;
*p<0.05 post-hoc Sidak’s multiple comparisons test n= 15, 12). N= 3 animals per group.
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2.3.7 Short-term plasticity at the SST-PN synapse is unaltered in DISC1
HET mice
We next measured the PPR of IPSCs evoked from Chr2+ SST INs onto layer II/III PNs in
mPFC Fig2.6A,B. A two-way ANOVA showed a significant effect of interval on PPR F(2, 50)
= 24.88, ****p<0.0001. However, there was no significant effect of genotype on PPR F(1, 25)
= 1.639, p= 0.21, nor was there a significant effect of genotype and interval on PPR F(2, 50)=
0.47, p= 0.63. SST GABA PPR was consistent between genotypes across all intervals tested
(p>0.05 Sidak’s multiple comparisons test) Fig2.6C,D.
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Figure 2.6: SST-evoked IPSC PPR is unchanged in DISC1 HET mice. A. Recording config-
uration: 1 ms blue light pulses were delivered at 50, 100, and 150 ms intervals to evoke IPSCs from
ChR2+ SST interneurons in mPFC. B. Representative traces from WT and DISC1 HET mice at 50, 100,
and 150 ms intervals. Black lines represent single trials, averaged traces in gray. C. DISC1 HET mice
exhibited the same GABA PPR as WT mice across the intervals tested. D. Boxplots show PPR data
was normally distributed and there were no significant differences between genotypes at any interval.
N=2 animals per group.
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2.3.8 Distinct decay kinetics of GABA transmission from PV vs. SST in-
terneurons
At first glance, IPSCs mediated by SST+ INs appeared to decay more slowly than those me-
diated by PV+ INs. Therefore, I compared the decay time constants calculated from the
normalized average peak IPSC recorded at the 150 ms interval in the GABA PPR experiment
Fig2.7A,B. Mann-Whitney tests with Bonferroni correction showed that IPSCs mediated by
PV INs had smaller half-widths and decay time constants than IPSCs mediated by SST INs in
both genotypes (WT: p= 0.03 n.s., **p<.01, HET: **p<.01, ****p<0.0001) Fig2.7C,D. This
is consistent with reported data regarding uIPSCs from FS/PV and LTS/SST interneurons to
pyramidal cells (Kobayashi et al., 2010; Ma et al., 2012) and suggests that IPSC decay kinetics
may be a useful measure to identify the source of inhibitory currents. There was no differ-
ence between genotypes for IPSC decay time constant (PV: p= 0.83 SST: p=0.06, two-tailed
t-test with Bonferroni correction) or half-width (PV: p=0.68, two-tailed t-test with Bonferroni
correction SST: p= 0.13, Mann-Whitney with Bonferroni correction).
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Figure 2.7: PV and SST INs exhibit distinct IPSC decay kinetics. A. Average normalized IPSCs
evoked by direct ChR2 stimulation of PV or SST INs in WT mice. Line represents mean and shading
corresponds to the 95% confidence interval. B. Average normalized IPSCs recorded in DISC1 HET mice.
C. IPSC half-width in PV and SST-mediated IPSCs, circles= WT, diamonds= HET. D. IPSC decay
time constant of PV and SST-mediated IPSCs. Scale bar= 100 ms.
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2.3.9 Conclusions
A set of changes in the mPFC circuitry were observed that suggests that PV interneuron
function is altered in the DISC1 HET mouse. Firstly, we found that the frequency but not
amplitude of spontaneous inhibitory transmission onto layer III pyramidal neurons was signif-
icantly reduced in adult DISC1 HET mice compared to WT littermates that had two copies
of the full-length DISC1 gene. Meanwhile, we found no difference in the frequency or am-
plitude of spontaneous excitatory transmission onto layer III pyramidal neurons in mPFC. A
reduction in mIPSC frequency is consistent with reduced GABA release probability, fewer in-
hibitory synapses onto PNs, or both. In order to investigate whether a presynaptic alteration
in GABAergic function contributed to reduced mIPSC frequency, we took advantage of Cre-
dependent ChR2 expression in the PV-IRES-Cre and SST-IRES-Cre mouse lines. By evoking
PV or SST-mediated IPSCs onto layer III pyramidal neurons, we were able to assess the short-
term dynamics of GABA transmission from these two major interneuron subtypes. We found
that the paired-pulse ratio of PV-evoked IPSCs onto pyramidal neurons was significantly in-
creased in DISC1 HET mice compared to WT, while there was no significant difference between
genotypes for SST-mediated IPSCs. Interestingly, we found no difference in the decay kinet-
ics of the PV-mediated IPSCs onto pyramidal neurons in DISC1 HET compared to WT. This,
along with the evidence that mIPSC amplitude is not affected, suggests that inhibitory synaptic
transmission is primarily affected at the presynapse.
In the PV/SST light-activated IPSC recordings, we observed that PV and SST INs
exhibited distinct properties in IN-PN transmission. In WT mice, there was a significant effect
of cell type on GABA PPR, with SST-evoked IPSCs exhibiting higher PPR than PV-evoked
IPSCs at the 50 and 100 ms interstimulus intervals. This pattern was similar to what was
observed when comparing FS-PN and SST-PN unitary inhibitory currents in layer IV barrel
cortex (Ma et al., 2012). However, because PV-evoked IPSC PPR was significantly increased
in the DISC1 HET mice, they did not exhibit a significant effect of cell-type on GABA PPR.
This is intriguing because normally, there is reciprocal relationship between the kinetics and
short-term plasticity properties of input and output synapses of PV and SST INs (Beierlein
et al., 2003; Ma et al., 2012). That is, EPSPs onto PV/FS INs are fast rising as are uIPSCs from
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PV/FS INs. In addition, PV-PN synapses depress during ongoing activity, making feedback
and feedforward inhibition through PV INs optimized to transmit transient information as
opposed to sustained information about ongoing behavior (Ma et al., 2012). Conversely, PN-
SST synapses exhibit slower kinetics in both directions, and SST-PN IPSCs facilitate. In the
PN-SST-PN circuit, SST-PN IPSCs are less temporally precise, but they are able to sustain
inhibition onto PN dendrites and potentially gate plasticity. If PV-mediated IPSCs in the
DISC1 HET mice do not rapidly depress, this may impair the ability of PV INs to precisely
transmit signals regarding transient stimuli.
This data suggests that genomic deletion of DISC1 primarily affects inhibitory as op-
posed to excitatory synaptic transmission onto pyramidal neurons in the prefrontal cortex. We
have not measured mIPSCs in other cortical areas, so we do not know whether this is a brain
region-specific effect. To date, studies assessing the neurophysiological effects of DISC1 defi-
ciency are surprisingly sparse (Duan et al., 2007; Hayashi-Takagi et al., 2010; Holley et al., 2013;
Kvajo et al., 2011; Maher & Loturco, 2012; Niwa et al., 2010). However, our finding is con-
sistent with another report of decreased spontaneous inhibitory transmission onto layer II/III
pyramidal neurons in mPFC of male mice expressing a truncated form of DISC1 (Holley et al.,
2013). DISC1 expression has been shown to be particularly high at the postsynaptic density
(Carlisle et al., 2011; Hayashi-Takagi et al., 2010; Kirkpatrick et al., 2006; Paspalas et al., 2013;
Wang et al., 2010) and consequently most investigations of DISC1’s effect on synaptic trans-
mission have focused on postsynaptic function. However, DISC1 is also expressed in axons and
presynaptic terminals (Kirkpatrick et al., 2006; Wang et al., 2010) and interacts with proteins
that are involved in axon cargo transport, vesicle docking, and exocytosis (Camargo et al.,
2007). The role of DISC1 in presynaptic function has been highlighted by two recent stud-
ies: frequency facilitation, a form of short-term plasticity, was reduced in the mossy fiber/CA3
circuit of truncated DISC1 mice (Kvajo et al., 2011) and glutamate release probability from
pyramidal neurons was shown to be reduced following in utero DISC1 knockdown in pyramidal
neurons (Maher & Loturco, 2012). Currently, the potential mechanisms of DISC1’s effect on
presynaptic release are unknown, although DISC1 knockdown was reported to slow the trans-
port of synaptic vesicles along the neuronal processes of cultured primary neurons (Flores et al.,
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2011).
While our study is the first to specifically assess the presynaptic function of inhibitory
interneurons in a DISC1 mouse model, other studies have made observations that hint at PV
dysfunction: reduced sIPSC frequency was seen in the frontal cortex of male mice expressing
a truncated form of human DISC1 (hDISC1) (Holley et al., 2013), reduced PV expression has
been observed in the PFC of many DISC1 models (Ayhan et al., 2010; Hikida et al., 2007; Ibi
et al., 2010; Lee et al., 2013a; Niwa et al., 2010; Shen et al., 2008), and tangential migration
of MGE-derived neurons is impaired (Lee et al., 2013b; Steinecke et al., 2012). While it’s been
shown that DISC1 is expressed in MGE-derived neurons, which include PV and SST INs, the
expression profiles of DISC1 (such as splice isoform expression, and subcellular localization) in
these INs are not known. Therefore differences in synaptic phenotypes in PV vs. SST in the
DISC1 HET background may be due to cell type differences in DISC1 expression profiles and
function. Single-cell RNA-seq studies that focus on genetically-defined populations of PV or
SST INs could shed light on the expression patterns of DISC1 in these two IN types.
One of the goals of this work was to evaluate whether DISC1 genomic deletion, which
decreases DISC1 expression by half brain-wide and presumably in all cell-types (Jaaro-Peled
et al. submitted), affects synaptic transmission differently than cell-type restricted postnatal
knockdown of DISC1. In order to assess synaptic function in defined populations of neurons, we
crossed the DISC1 heterozygous mice into the PV-IRES-Cre; Ai14 and SST-IRES-Cre; Ai14
reporter lines. This approach allows us to assay the effect of DISC1 deletion in defined cell types
within a haploinsufficiency model that is believed to mimic the effects DISC1 translocation. We
were interested to compare the mini recording results collected from HET mice to recordings
collected from cell-type restricted knockdown. In the SST INs, we observed a significant increase
in the mEPSC amplitude onto SST INs in heterozygous and SST-specific DISC1 knockdown
experiments. This suggests that DISC1 expression alters SST postsynaptic function in a manner
that is “cell-autonomous.”
Meanwhile, we found that mEPSCs were not different onto PV INs of DISC1 HET mice,
but PV-restricted DISC1 knockdown increased mEPSC frequency onto PV INs. This finding is
a little surprising given that a change in frequency suggests an effect at the presynapse, where
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DISC1 expression was not altered. However, one possibility is that the increased mEPSC
frequency seen in the PV DISC1 knockdown was a homeostatic response to increased network
activity (possibly caused by reduced PV IN function following DISC1 knockdown) (Chang et al.,
2010). The fact that we did not observe this effect in the DISC1 heterozygous mice suggests
that either the timing of DISC1 loss, or the cumulative impact of DISC1 loss within all neurons
of the network differentially influence excitatory input on PV INs. Compared to SST INs,
this suggests that the impact of DISC1 loss in PV INs may be more affected by the function
of the network. This may be consistent with the observation that PV expression is reduced
when DISC1 expression is disrupted in pyramidal neurons (Brandon & Sawa, 2011). An open
question is whether the DISC1 heterozygous effects such as the reduced mIPSC frequency or
increased PPR from PV INs can be recapitulated by PV-restricted DISC1 knockdown. The
fact that we observed reduced mIPSC frequency in preweanling DISC1 HET mice suggests that
this impairment is a result of early developmental mechanisms, and not necessarily related to
the “second wave” of DISC1 expression during adolescence (Schurov et al., 2004).
Table 2.1: Summary of synaptic effects in DISC1 heterozygous and DISC1 knockdown ex-
periments
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Chapter 3
Feedforward inhibition in the
MD-mPFC projection
3.1 Introduction
In this chapter, we probed the function of the thalamocortical projection from the mediodorsal
thalamus (MD) to the dorsal anterior cingulate cortex (dACC). In the second chapter of this
thesis, we found that the frequency of mIPSC transmission onto layer III PNs in the mPFC was
reduced and that the PPR of PV IN-mediated IPSCs onto layer III PNs was increased in the
DISC1 HET mice. These findings point to an impairment in mPFC PV-PN GABA transmission
in the context of DISC1 loss-of-function. It has been proposed that reduced GABA signaling
from PV INs in the DLPFC could contribute to the pathophysiology of working memory impair-
ments in SZ (Lewis, 2009), in keeping with evidence that GABA transmission is important for
working memory (Enomoto et al., 2011; Sawaguchi et al., 1989). One mechanism by which PFC
GABA transmission could be impaired is reduced feedforward inhibition from the mediodorsal
thalamus which sends direct projections to layer III and V pyramidal and inhibitory neurons
in the PFC (Kuroda et al., 2004; Rotaru et al., 2005). Lesion of the mediodorsal thalamus pro-
duces cognitive impairments that in many ways resemble those caused by PFC lesion (Mitchell
& Chakraborty, 2013) suggesting that communication between the MD and mPFC is crucial
for behavioral flexibility and working memory processes. Feedforward inhibition is important
for narrowing the window of excitatory integration and thus sharpening spike timing (Pouille
& Scanziani, 2001), and is thus predicted to be an important mechanism for filtering out weak
responses and synchronizing the firing of neuronal assemblies that are potentially involved in
the same task (Engel & Singer, 2001).
To date, the role of PV IN function in the normal activity coupling between the MD and
mPFC is unexplored, although intriguingly, functional connectivity between the MD and PFC
is reduced in individuals with SZ (Mitelman et al., 2005; Schlosser et al., 2008; Seidman et al.,
1994; Zhou et al., 2007). PV INs have an established role in generating gamma oscillations
(Cardin et al., 2009; Sohal et al., 2009), which increase in the DLPFC with working memory
load (Howard et al., 2003) and are weaker in people with SZ (Cho et al., 2006; Minzenberg
et al., 2010). Therefore, impaired regulation of PN excitatory integration by PV INs could lead
to impairments in gamma oscillations and, therefore, working memory (Lewis, 2009). While the
schizophrenia literature has focused much of its attention of gamma oscillations, more subtle
elevations in E/I balance are also predicted to perturb working memory (Mar´ın, 2012).
The seminal work of Patricia Goldman-Rakic revealed that persistent firing of spatially-
tuned PFC pyramidal neurons during delay periods predicted performance on a delayed oculo-
motor WM task (Funahashi et al., 1989), and that increasing E/I balance via GABAA antag-
onism destroys spatial tuning of delay period neurons in primate DLPFC (Rao et al., 2000).
In a computational model of working memory that includes 2 key network properties – strong
recurrent excitation to sustain persistent activity and lateral inhibition to shape selectivity of
representation – introducing disinhibition leads to higher baseline firing rates and broadened
working memory activity patterns (Murray et al., 2014). At the behavioral level, disinhibition
accelerates the deterioration of the precision of information held in WM. Such deterioration
would be predicted to impair working memory performance on shorter delay trials than when
E/I is balanced. In DISC1 mouse models, the most commonly observed changes seen across
models are reduced PV expression in the PFC and impaired working memory performance
(Ayhan et al., 2010; Brandon & Sawa, 2011; Clapcote et al., 2007; Hikida et al., 2007; Koike
et al., 2006; Kvajo et al., 2008; Niwa et al., 2010; Shen et al., 2008), raising the question of
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whether E/I balance is altered in DISC1 HET mice. Although the data suggests that DISC1
expression may be required for normal PV expression, the surprising thing is that it is required
in a non-cell-autonomous way. That is, expressing a truncated for of DISC1 downstream of
the CaMK promoter (Hikida et al., 2007), or the transient knockdown of DISC1 in migrating
pyramidal neurons (Niwa et al., 2010), both produce reductions in PV expression. Regardless,
the co-occurring changes in mPFC PV expression and working memory performance suggests
that PV pathophysiology might be the link between altered DISC1 expression and working
memory impairment.
3.1.1 The role of PV+ INs in thalamocortical projections
To aid in the understanding of the potential role of feedforward inhibition in the mPFC, there
is rich body of literature from TC circuits in the sensory cortices. Intracortical glutamatergic
synapses predominate over thalamocortical glutamatergic synapses in the cortex, with an esti-
mated 10-23% of synapses onto cortical neurons in the thalamorecipient layer being of thalamic
origin (Benshalom & White, 1986). A recent study that isolated thalamic excitatory contri-
bution to V1 by optogenetically activating PV+ INs to silence intracortical communication,
found that thalamic excitation contributes roughly a third of the total excitation in V1 (Lien &
Scanziani, 2013). Lien et al. observed that isolated thalamic and total excitation were similarly
tuned to orientation and direction, suggesting that the primary function of cortical circuits is
to amplify tuned thalamic input. The pattern and magnitude of this TC amplification should
depend largely on the function of inhibitory interneurons that are either recruited directly by
the thalamus (feed-forward) or by local cortical pyramidal neurons (feed-back). Feed-forward
inhibition, the faster of the two, is capable of truncating ongoing TC responses, thus suppress-
ing spikes in neurons that receive weak TC input and imposing temporal precision on neurons
that reach threshold.
In order for inhibitory interneurons to shape the receptive fields of neighboring pyra-
midal neurons, they must be more effectively recruited by TC inputs. TC recruitment of
feed-forward primarily through fast-spiking PV interneurons is well-studied in the VPM-barrel
cortex circuit (Agmon & Connors, 1992; Cruikshank et al., 2007; Daw et al., 2007; Gabernet
60
et al., 2005; Gil & Amitai, 1996; Porter et al., 2001; Sun et al., 2006; Swadlow, 2002). Single
unit recordings in vivo have also shown that fast-spiking inhibitory INs demonstrate robust
responses to thalamocortical (TC) activation. The basis for robust recruitment of FS INs ap-
pears to be due to larger excitatory conductances rather than intrinsic mechanisms (Cruikshank
et al., 2007). Furthermore, the threshold for IPSP recruitment in the TC pathway is signifi-
cantly lower than the threshold within intracortical circuits (Gil & Amitai, 1996). As FS IN-
mediated feed-forward inhibition has been observed in a wide range of cortical areas (Miller
et al., 2001; Pouille & Scanziani, 2001; Wehr & Zador, 2003), it is believed to be a fundamental
property of the TC microcircuit. Therefore, we hypothesized that the same mechanisms should
be in place within prefrontal cortex, whose long-range afferents it has only recently become
possible to study with the advent of optogenetics (Cruikshank et al., 2012).
In this section, we took advantage of the ability to directly excite ChR2-expressing
axons and terminals in order to trigger neurotransmitter release in the prefrontal cortex. This
method of viral transduction in one brain region and illumination of downstream axons makes it
possible to interrogate long-range projections between the thalamus and prefrontal cortex that
would be severed in most practical slice preparations (Yizhar et al., 2011) and has successfully
been used to study TC projections in other cortical areas (Cruikshank et al., 2010; Hooks et al.,
2013; Petreanu et al., 2007). We sought to functionally validate the reported projection from
MD to PV INs and determine if PV INs mediate thalamocortical feedforward inhibition onto
layer III PNs. We then compared the ratio of GABA : AMPA currents recruited onto layer
III PNs by MD afferent stimulation in DISC1 WT and HET mice with the hypothesis that
GABA : AMPA ratio would be reduced in DISC1 HET mice. Finally, we performed a set of
inhibitory optogenetic experiments to test whether PV silencing abolishes MD-evoked IPSCs.
Below I outline the background of the mediodorsal thalamus, its pathology in schizophrenia,
and its proposed function in recruiting feedforward inhibition in the mPFC.
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3.1.2 General anatomy/connectivity of MD
The mediodorsal thalamus is classified as a higher order relay nucleus as it’s been reported to
receive “driver” inputs from layer V of prefrontal cortex (Sherman & Guillery, 2002) and in
contrast to primary relay nuclei that receive sensory information directly from the periphery, the
mediodorsal thalamus receives little to no sensory input. The MD exhibits extensive reciprocal
connections with the prefrontal cortex, and in fact, the prefrontal cortex is generally defined as
the frontal region of the brain that receives input from the MD. Thalamocortical projections
generally terminate in cortical layer IV, and neurons in layer VI – and to a lesser extent V –
project back to the thalamus. In well-studied thalamocortical loops such as the VB to the barrel
cortex, coupled thalamic and cortical regions exhibit functional similarities. Ultrastructural
studies have shown that layer VI axons have small terminals that contact peripheral dendritic
segments, layer V axons are large and contact the dendritic segments. This has led to the
idea that layer V inputs act as “drivers” whereas layer VI inputs modulate thalamic neuron
activity (Guillery, 2003) The fact that MD exhibits specific and reciprocal connections with
the prefrontal cortex suggests that it participates in limbic and cognitive processes that the
prefrontal cortex participates in, and there are reported to be a small number of layer V
corticothalamic neurons that receive direct input from MD and send their axons to MD (Kuroda
et al., 1993). Evidence of the importance of cortical activity for second-order thalamic activity
comes from inactivation studies that found while primary thalamic nuclei are minimally affected
by cortical inactivation, second-order thalamic nuclei become unresponsive to peripheral input,
highlighting the driving influence of cortical input for second-order relays (Diamond et al.,
1992). Cooling of the PFC was demonstrated to decrease firing rates in the MD, suggesting
that MD likewise receives substantial cortical drive (Alexander & Fuster, 1973).
In rats, extensive electron microscopic studies have shown that MD efferents terminate
primarily in layer III – and to a lesser extent I and V – forming asymmetric synapses onto the
apical dendrites of pyramidal cells whose somata lie in layers III and V in the mPFC (Kuroda
et al., 1995b, 1996; Rotaru et al., 2005; Vogt et al., 1981). Due to differences in dendritic
branching within layer III, it is believed that pyramidal neurons whose somata lie in layer III
are more greatly influenced by MD inputs than layer V pyramidal neurons (Kuroda et al.,
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1996). At least some of these layer III thalamorecipient neurons project callosally (Kuroda
et al., 1995a). However, another study that looked at callosal and thalamic afferents to cingulate
cortex together found that the terminal fields were largely non-overlapping, suggesting that MD
mainly targets the output neurons of the cortex (Vogt et al., 1981). In addition, MD afferents
also form synapses onto the dendritic shafts of GABAergic INs in layer III and V of mPFC
(Kuroda et al., 2004, 1996), particularly those that express parvalbumin (Rotaru et al., 2005).
Ultrastructural findings are summarized in Fig3.1.
63
To contralateral
PFC
MD relay neuron
?
I.
II.
III.
V.
VI.
PV+
Inhibitory
Interneuron
    
 
            
Pyramidal
neuron
Dendritic spine
Excitatory terminal
Inhibitory terminal
Figure 3.1: Summary of existing anatomical data for MD-PFC projection MD axons primarily
form asymmetric synapses onto the dendritic spines of pyramidal neurons whose somata lie in layer III
and V in dACC. It’s believed that due to the position of their basilar dendrites, layer III PNs receive
the most input from MD. Axon terminals also make asymmetric synapses onto the dendritic shafts on
inhibitory interneurons, particularly those that label for parvalbumin.
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The boundaries of the thalamic and prefrontal regions are poorly defined, and there has
been extensive debate over what the equivalent prefrontal cortical regions are across species
and where the divisions should be drawn (Heidbreder & Groenewegen, 2003; O¨ngu¨r & Price,
2000; Van De Werd et al., 2010; Vogt & Vogt, 2004). This had led to some confusion in the
literature as to whether the MD primarily projects to the cingulate cortex or the prelimbic
cortex.The mediodorsal thalamus (MD) can be parcellated into roughly three subnuclei: the
medial (magnocellular), central, and lateral (parvocellular) MD that exhibit different topogra-
phies of afferent and efferent projections (Groenewegen, 1988). Importantly, the pattern of
thalamocortical and corticothalamic terminations are topographically similar. The medial por-
tion of the MD is believed to be most reciprocally connected the ventral portion of the mPFC
(PrL/IL); the central portion mainly has reciprocal connectivity with the ventral granular in-
sula and lateral orbital areas; the lateral portion of the MD meanwhile is reciprocally connected
with the dorsal anterior cingulate cortex (Groenewegen, 1988).
A recent tracing paper reassessed the MD-PFC pathway in mouse and made several
observations that are in disagreement with the previous literature in rats (Matyas et al., 2014).
First, they found that small injections of the retrograded tracer CTB into MD consistently
labeled neurons in M2 and dACC, with only a few scattered cells found in PrL and IL. CTB in-
jections into dACC labeled the lateral MD, similar to earlier anatomical studies that observed
a topographical relationship with dorsal PFC receiving input from the lateral MD Fig3.2A
(Groenewegen, 1988; Ray & Price, 1992). Conversely, CTB injection into PrL labeled neurons
in the medial “transition zone” of the MD/midline thalamic nuclei (Matyas et al., 2014). This
pattern was also consistent with retrograde labeling from the PrL primarily labeled neurons in
the medial portion of the MD Fig3.2B. The topography of PFC-MD inputs may have been
missed by earlier studies that concluded the MD projects principally to the PrL because injec-
tion sites were often large spread into the midline thalamic nuclei Fig3.2C. Consistent with the
Matyas et al. findings, another tracing study also concluded that axons from the MD primarily
project to layer III of the dACC (Wang & Shyu, 2004). Secondly, Matyas et al. observed that
the dorsal/ventral border of dACC and PrL could be defined by a sudden drop off in parval-
bumin staining in the superficial layers of PrL (Matyas et al., 2014). This paper highlights
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the importance of independently validating brain region connectivity before attempting circuit-
based physiology studies, and presents interesting chemoarchitectonic parameters to distinguish
dACC from PrL.
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Figure 3.2: Retrograde tracing from dACC and PrL reveals topographical separation of
thalamic projection. A. CTB injections into dACC labels projection neurons in the central/lateral
portion of the MD (from Matyas et al. 2014). Right panel, red outline shows retrogradely labeled
neurons in MD after cingulate injection (from Ray et al. 1992). B. Conversely, CTB injection into PrL
label projection neurons in the most anteromedial portion of the MD, which Matyas et al. refer to as
a transition zone with the midline thalamic nuclei. Right panel shows pattern of retrogradely neurons
along medial MD following injection into PrL (Ray et al. 1992). C. Injection location from Kuroda
et al. 1995 that was used to evaluate the projection patterns of MD axons to the mPFC. Note the
spread of wheat germ-agglutinin-horseradish peroxidase (WGA-HRP) into the neighboring midline and
intralaminar thalamic nuclei. VGlut2 staining was used as a marker for the rostral MD/midline transition
zone, as midline nuclei receive stronger glutamatergic afferents from the brainstem than MD does. Scale
bar = 1 mm.
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The major input sources to the MD include the PFC, piriform cortex, olfactory tuber-
cle, the basal amygdala (recently contested, see (Matyas et al., 2014), the ventral pallidum, the
thalamic reticular nucleus (TRN), the superior colliculus, the substantia nigra pars reticulata,
and the dorsal tegmental area (Kuroda et al., 1998; Ray & Price, 1992). Notably, the MD
receives inputs from dopamine-rich regions of the limbic system, such as the nucleus accum-
bens, ventral tegmental area, and ventral pallidum. It has been shown in vitro that dopamine
increases the intrinsic excitability of relay neurons in the MD (Lavin & Grace, 1998). The
MD receives GABAergic input from two main sources; the ventral pallidum and the substantia
nigra pars reticulata, with minor GABAergic projections from the substantial innominata, the
zone incerta, the vertical limb of the diagonal band, and the ventral pallidal parts of the olfac-
tory tubercle (Bartho et al., 2002; Churchill et al., 1996; Kuroda & Price, 1991a,b; Mitchell &
Chakraborty, 2013).
3.1.3 MD dysfunction in schizophrenia
While most attention has focused on structural and molecular changes in the prefrontal cortex,
other areas such as thalamus, hippocampus, and basal ganglia demonstrate volume reduction in
patients with SZ. The MD has been reported to have fewer cells in patients with SZ compared to
healthy controls (Heckers, 1997; Popken et al., 2000; Young et al., 2000). While several studies
report robust reductions, such that there is virtually no overlap in cell numbers between control
and SZ groups (Young et al., 2000), another study reported a modest reduction in MD volume
but no difference in cell density (Danos et al., 2005). Interestingly, one of the earliest reported
and most stable findings of brain structure abnormalities in schizophrenia is an enlargement of
the lateral ventricles (Andreasen, 1997). Ventricle enlargement may be explained, in part, by
reduced volume in the thalamus, which lies adjacent to the lateral ventricle: in fact, a group
found that thalamic volume– particularly the MD– inversely correlated with ventricle volume
(Gaser et al., 2004).
Functional imaging studies have also shown a reduction in the resting state and working
memory task-dependent functional connectivity between the MD and the PFC in chronic and
first episode SZ patients (Mitelman et al., 2005; Schlosser et al., 2008; Seidman et al., 1994;
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Zhou et al., 2007). A meta-analysis of 41 neuroimaging studies of executive function in patients
with SZ and healthy controls reporter a consistent pattern of reduced activation in bilateral
DLPFC, ACC, and MD (Minzenberg et al., 2009). Several other studies have found evidence for
reduced gray matter density in both MD and the PFC (Ananth et al., 2002; Brickman et al.,
2004; James et al., 2004; Marenco et al., 2012; Mcintosh et al., 2004; Rose et al., 2006). A
recent study reported that a significantly reduced connectivity between the MD and the ACC
was detected in patients compared to controls, and connectivity was inversely correlated with
Stroop task performance (Wagner et al., 2013). This provides further support for dysregulation
of the thalamofrontal network in schizophrenia.
3.1.4 MD function
More than a mere relay, the MD appears to integrate information from PFC, limbic structures,
and basal ganglia to flexibly adapt behavior. A recent study by Parnaudeau et al. showed that
chemicogenetic inhibition of MD neurons disrupts acquisition and performance in a T-maze
working memory task (Parnaudeau et al., 2013). A similar impairment in delayed non-match
to sample (DNMS) performance was shown by pharmacologically inactivation of MD (Floresco
et al., 1999; Romanides et al., 1999). The subtle reduction in MD firing rate caused by CNO
administration was accompanied by a disruption of choice phase associated MD-mPFC beta
(13-30 Hz) frequency synchrony. Interestingly, the power spectra in MD and mPFC were
not affected, suggesting that reducing MD activity didn’t weaken beta oscillation power per
se but rather disrupted the connectivity between the two regions. Furthermore, lag analysis
suggested a predominant MD to mPFC directionality in the beta frequency range, consistent
with prospective choice information in the T-maze flowing from the MD to the mPFC.
This finding is reminiscent of recordings by Watanabe et al. in nonhuman primates
during a saccade task that showed that a greater number of MD neurons exhibit pre-saccadic
activity than in the DLPFC, where neuronal responses were mainly post-saccadic. Most in-
terestingly, they observed that during an anti-saccade task, in which a visual cue prompts the
subject to saccade away from the visual stimulus after a delay, the direction of population
vectors in MD rotated away from the cued direction towards the saccade direction early in
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the delay period (Funahashi et al., 2004; Watanabe & Funahashi, 2012; Watanabe & Takeda,
2009). This shift of neural population activity towards the saccade target direction preference
began earlier in the MD than in the DLPFC, suggesting that the MD conveys information
to the PFC regarding future actions. Impaired performance of mice in the DNMS task could
therefore reflect the inability of the MD to convey or maintain “on-line” the choice motor plan
to the mPFC during the delay period between arm selection and outcome. The inability to
maintain a prospective choice representation could impair the mouse’s ability to evaluate its
choice and update its strategy based on feedback for the subsequent trial. While the Par-
naudeau study suggests that MD conveys prospective choice information to mPFC, another
recent study reported that single unit activity patterns during the delay period of a working
memory task more strongly represented a mouse’s previously chosen goal than the upcoming
goal (Han et al., 2013). In addition, another rodent study found that during an instrumental
learning task, most task-related firing in MD occurred after reward delivery, suggesting that
the MD-mPFC circuit may be more involved in evaluating feedback than encoding choice (Yu
et al., 2012). However, one earlier study did observe conditioned behavior-related neurons that
increased their activity just prior to licking to avoid a shock or receive a reward. Notably, the
small number of units they found that fit this profile were located in the lateral portion of the
MD (Oyoshi et al., 1996). Therefore, the activity of MD units may depend on the topographical
projections of the MD subregion. For example, the lateral portion of the MD projects to the
motor-planning related areas of the the mPFC (M2 and dACC). Therefore, it may be predicted
that MD neurons in the lateral portion of the MD may exhibit more prospective motor-related
activity.
The MD is not only implicated in working memory performance; inactivation and lesion
studies in rat showed that lesioning the MD didn’t impair single object recognition but impaired
object-in-place and recency recognition memory (Cross et al., 2013; Mitchell & Dalrymple-
Alford, 2005). These impairments were nearly identical to what was seen when mPFC alone is
lesioned, suggesting that MD and mPFC are important for recognizing objects and cues (and
perhaps selecting an appropriate behavioral response) within a given context (Cross et al., 2013;
Hannesson et al., 2004). Interestingly, MD lesion studies in primates have revealed that there is
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some distinction between the impairments caused by MD lesion vs. mPFC lesion; namely, MD
lesion impaired memory of a new set of objects-in-scene while it spared the monkey’s ability
to implement the task strategy it had previously learned (Baxter, 2013). Reminiscent of the
recency findings in rats, it seems that MD is involved in binding contextual information (in
this case the background scene) to a perceived object (in this case the rewarded/non-rewarded
embedded cue) in order to facilitate later retrieval and behavioral response.
Likewise, it’s predicted that the MD could function to reverse such cue/context associ-
ations in order to flexibly adapt in the face of updating reward contingencies. This hypothesis
is consistent with a recent study in mice that found that chemicogenetically inhibiting MD
impaired the ability to adapt to changing contingencies between actions and outcomes (Par-
naudeau et al., 2014). Namely, the authors found an impairment in reversal learning and
outcome-specific Pavlovian-to-instrumental transfer (PIT). Interestingly, MD inhibition during
the Pavlovian training, but not the PIT testing itself reduced the tendency of mice to make
an instrumental response to the congruent side that the CS had been been paired with dur-
ing the Pavlovian training. This suggests that inhibiting MD during learning impaired the
mouse’s ability to later retrieve the stimulus-outcome association in order to guide action selec-
tion during the PIT test. In keeping with the result that MD inhibition doesn’t impair simple
Pavlovian conditioning, ablating mPFC neurons that project to MD with tetanus toxin did not
alter contextual or cued fear conditioning (Xu & Su¨dhof, 2013).
The MD has also beens studied for its role in conveying nociceptive information to
the dACC to regulate the affective and autonomic response to pain. A number of studies
have observed nociceptive responses in the MD and neighboring centrolateral nucleus (CL)
(Sikes & Vogt, 1992; Wang et al., 2003; Whitt et al., 2013). Interestingly, MD and dACC
responses appear at the very onset of a cue that leads to painful stimulation, suggesting that
they encode an anticipatory (or motivational) response to pain-related environmental changes
(Wang et al., 2003). One study found that lidocaine infusion into the medial thalamic area (not
specifically MD) blocked unit responses in the dACC to noxious electrical stimulation (Sikes
& Vogt, 1992). Interestingly, the researchers noted that the majority of responsive units were
found in layer III, consistent with the MD-dACC projection pattern we’ve observed. They
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also noted that there was an initial period of inhibition in response to nociceptive stimulation
and suggested that it was caused by inhibitory INs that are directly recruited by the MD. A
more recent study found that spinal cord injury increased the spontaneous firing rates of MD
units and increased the magnitude and duration of responses to noxious stimuli (Whitt et al.,
2013). Similar changes were observed by pharmacologically inactivating the zone incerta (ZI)
(which leads to immediate hyperalgesia), suggesting that spinal cord injury alters MD response
properties via disinhibition through the ZI. Intriguingly, chronic pain is often associated with
working memory impairments (Moriarty et al., 2011), and in mice, inflammatory pain impaired
spatial working memory performance and caused a global decrease in MD-mPFC connectivity
(Cardoso-cruz et al., 2013). This pain-induced change MD-mPFC connectivity and working
memory impairment has striking parallels to reduced activation of the DLPFC, AAC, MD
network seen in individuals with SZ (Minzenberg et al., 2009).
In a study by Floresco et al., repetitive burst stimulation in MD produced robust,
short-term potentiation of hippocampal-evoked firing in mPFC neurons (Floresco & Grace,
2003). The ability of MD to gate PFC neuronal responses to hippocampal input raises the
intriguing possibility that MD is involved in strategy selection by either supporting or blocking
associational plasticity at hippocampal-PFC synapses. Two studies suggest that synaptic po-
tentiation in the MD-mPFC pathway is an important component in acquisition and retention
of fear extinction memory. Low frequency stimulation (LFS) of the MD prior to extinction
training was shown to induce LTD in the MD-mPFC pathway and impair the maintenance of
extinction memory (Herry & Garcia, 2002). Interestingly, LFS of the ventral hippocampus im-
mediately after extinction training also induced LTD in the MD-mPFC pathway and impaired
extinction recall (Hugues & Garcia, 2007). Because MD is not directly connected to vHipp,
vHipp LFS-induced synaptic depression in the MD-mPFC pathway could occur downstream
as associative LTD in neurons that receive convergent input from vHipp and MD. The Hugues
study found that LTP in the vHipp-mPFC and MD-mPFC projections were a normal part
of extinction learning. Potentiation first occurred in the vHipp-mPFC during early extinc-
tion training, whereas MD-mPFC potentiation peaked 7 days post extinction training, when
vHipp-mPFC field potentials had returned to baseline. This suggests that during the course
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of extinction learning the extinction memory is transferred from the vHipp-mPFC pathway to
the MD-mPFC pathway.
3.1.5 Evidence for MD recruitment of PV interneurons
In addition to synapses onto dendritic spines of PNs, MD afferents form synapses onto the
dendritic shafts of GABAergic INs (Kuroda et al., 2004, 1996), particularly those that express
parvalbumin (Rotaru et al., 2005). It has also been shown that pharmacological disinhibition
of MD results in cfos expression of mPFC neurons that colabel for parvalbumin, as well as
calbindin and VIP (Bubser et al., 1998). Of course, it could not be determined from this study
if interneurons are activated via direct recruitment from the thalamus or indirectly via local
pyramidal neurons. The projection pattern of MD axons delineates a circuit whereby MD
afferents excite both layer III and V pyramidal neurons that project to contralateral mPFC
or to subcortical areas such as the ventral striatum. PV+ INs that receive monosynaptic
excitatory input from MD are then poised to inhibit callosal or subcortically-projecting neurons
via feedforward inhibition. A still unresolved issue is to what extent projection neurons in
dACC that project to MD receive direct input from the thalamus, that is, is there a closed
loop? An earlier tracing study reported that MD afferents synapse onto layer V CT PNs that
project back to MD (Kuroda et al., 1993), and a recent paper reported recording from a layer
V neuron that was labeled by retrobeads injection into MD (Lee et al., 2014). CTB tracing
labels dACC neurons primarily in layer VI, although it’s proposed that MD receives “driver”
input from layer V projection neurons. Evidence for cortical driver inputs to MD comes from
PFC cooling experiments (Alexander & Fuster, 1973). MD ChR2-evoked recordings from MD
CTB or retrobead labeled neurons in dACC should clarify this issue. It would be of interest
to assess whether neurons that project to the MD receive stronger feedforward inhibition, as is
suggested by a recent study (Lee et al., 2014).
In vivo electrophysiology results support the idea that MD recruits feedforward in-
hibitory circuits within the mPFC. Floresco et al. observed that the main effect of stimulating
MD was to inhibit PFC neuronal firing in response to hippocampal efferent stimulation (Floresco
& Grace, 2003). The temporal window during which MD stimulation gated hippocampal-evoked
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firing was 25-100 ms, consistent with its potential role in shaping the response properties of
PFC pyramidal neurons to coincident input. Other studies have detected convergent input from
MD and hippocampus onto single PFC pyramidal neurons and observed that MD stimulation
produces an EPSP-IPSP sequence (Gigg et al., 1994). While it has been proposed that MD
axons activate fast-spiking interneurons (Floresco & Grace, 2003), to date this has not been
demonstrated. There are several predicted differences in the MD-mPFC pathway compared to
the VB-barrel cortex pathway: 1) there is no layer IV in mPFC, therefore the major thalam-
orecipient layer is layer III 2) the mPFC compared to sensory cortices exhibits a high degree of
recurrent connectivity (Mason et al. 1991; Thomson et al. 1993; Wang et al. 2006) which may
promote the recruitment of feedback inhibition to a greater degree.
3.2 Methods
3.2.1 Animals
For rabies tracing experiments, PV-Cre;Rosa26-stopflox-tTA mice were used. For feedforward
inhibition experiments, I crossed DISC1 HET PV-IRES-Cre; Ai14 mice to PV-IRES-Cre;
Ai14 WT mice. Because the parents were heterozygous for Cre and Ai14 the offspring were
either WT or DISC1 HET and were either positive for both Cre and Ai14 – and thus labeled
PV+ INs red – or only carried Cre or Ai14 and thus did not label PV+ INs. PV-IRES-
Cre; Ai14 “reporter” mice were used in experiments that required targeted recordings of PV+
INs, whereas“reporter” and “non-reporter” mice were used in experiments that only involved
pyramidal neuron recordings. For DREADD and halorhodopsin experiments PV-IRES-Cre
and SST-IRES-Cre mice were used that were not crossed onto the DISC1 background or Ai14
background. Male and female mice were used for all recordings.
3.2.2 Stereotaxic surgery, viral constructs, and perfusion
Mice were stereotaxically injected unilaterally with adeno-associated virus (AAV) vector coding
ChR2(H134R)-YFP under control of the CAG promoter into mediodorsal thalamus between
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P40-P45. Surgical procedures were carried out as previously described. The stereotaxic coor-
dinates used for MD were as follows: A/P -1.58 mm; M/L -0.44 mm; D/V -3.20 mm. Surgical
procedures were standardized to minimize the variability of AAV injections, using the same
stereotaxic coordinates for MD and the same amount of AAV injected for all mice. To en-
sure minimal leak into surrounding brain areas, injection pipettes remained in the brain for
approximately 5 minutes post-injection before they were slowly withdrawn. Therefore, due to
capillary action, the final injected volume of CAG-ChR2 AAV was between 0.3 and 0.35 ul
( 1012) virus molecules per ml). Recording experiments were performed 3-4 weeks later, when
coronal mPFC slices were cut at 300 um thickness. For each mouse, MD containing slices were
cut at 350 um and imaged to examine the location and extent of ChR2 expression in the MD.
Mice were excluded if the extent of infection was either too large and leaked into surrounding
brain regions (e.g. hippocampus) or if expression was too low. Rodent MD lacks interneurons;
therefore all ChR2 infected neurons are expected to be relay projection neurons (Kuroda et al.,
1998).
For CTB tracing I injected 0.2 ul (2% in phosphate-buffered saline) mixed with 0.3uL
of AAV-CAG-ChR2-YFP virus in order to label MD axons and mPFC CT neurons. 1 week
later, mice were perfused intracardially with cold phosphate buffered saline (PBS) for 1 min
and 4% paraformaldehyde (PFA) in PBS for 5 min. Brains were removed immediately from
the skull and placed in PFA for 12 hours and then in 30% sucrose in PBS solution for 24
hours. 50-um thick slices were cut using freezing microtome (Leica SM 2010R, Leica). After
washing sections with PBS (3x 5 mins), sections were mounted onto slides with Fluoromount-G
mounting medium (Beckman Coulter).
For combined MD ChR2 and mPFC PV or SST halorhodpsin experiments, in addition
to the MD injection procedure previously described, PV-IRES-Cre or SST-IRES-Cre mice were
stereotaxically injected with 0.5 ul of DIO-eNpHR3.0 virus into the dorsal mPFC: A/P 1.94
mm; M/L -.34 mm; D/V. Mice were injected at approximately P45 and recorded 3-4 weeks
later.
75
3.2.3 Electrophysiology
Slice preparation was performed as described in Chapter 2 methods. The internal solution for
voltage-clamp experiments recording MD-axon evoked IPSCs and EPSCs contained 140 mM K
Gluconate, 10 mM HEPES, 2 mM MgCl2, 0.05 mM CaCl2, 4 mM MgATP, 0.4 mM NaGTP,
10 mM Na2-Phosphocreatine, 10 mM BAPTA, and 6 mM QX-314, with pH adjusted to 7.25
and diluted to 290 mOsm. IPSC reversal (EIPSC) was first determined by recording IPSCs in
the presence of AMPA (5 uM CNQX) and NMDA blockers (100 uM AP-5) at varying holding
potentials (20 mV steps) and measuring the IPSC amplitude. A linear regression was used
to calculate the best fit line, and the x-intercept was used as the EIPSC. Under our recording
conditions, the EIPSC was ∼-60 mV. IPSCs were recorded at 0 mV, and the only drug applied
to the bath for EI experiments was 100 uM AP-5. For cell-attached spike and current-clamp
experiments, the internal solution consisted of 130 mM potassium gluconate, 5 mM KCl, 10
mM HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM sodium phophocreatine
and 0.6 mM EGTA (pH 7.2).
To evoke synaptic transmission using ChR2, we used a single-wavelength LED system
(λ = 470 nm, CoolLED.com) connected to the epifluorescence port of the Olympus BX51
microscope. To restrict the size of the light beam for focal stimulation, a built-in shutter along
the light path in the BX51 microscope was used. Light pulses of 0.5 ms triggered by a TTL
(transistor-transistor logic) signal from the Clampex software (Molecular Devices), were used to
evoke synaptic transmission from ChR2+ MD axon terminals onto layer III neurons in mPFC.
To activate halorhodopsin neuronal inhibition, two Red LED (λ = 625 nm, Luminus, CBT-40
series) were used. The LEDs were secured at an angle oblique to the surface of the bath solution
(∼20 degrees) and were simultaneously triggered by a TTL signal from the Clampex software
(Molecular Devices). The intensity at the sample was ∼0.8 mW/mm2. For PV both and SST
halorhodopsin experiments, the Red LEDs were triggered 5 ms prior to ChR2 stimulation (0.5
ms pulse) for a total continuous light pulse duration of 20 ms.
In order to measure NMDA vs. AMPA mediated currents in response to MD stimulation,
I recorded responses at -70 mV and +40 mV in the presence of PTX (100 uM). The internal
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solution for this recording included 115 mM cesium methanesulphonate, 20 mM CsCl, 10 mM
HEPES, 2.5 mM MgCl2, 4 mM Na2-ATP, 0.4 mM Na3GTP, 10 mM sodium phosphocreatine
and 0.6 mM EGTA (pH 7.2). NMDAR-mediated responses were quantified as the mean current
between 110 ms and 160 ms after stimulation.
3.2.4 PV monosynaptic rabies tracing from mPFC
Cre-dependent monosynaptic rabies tracing was performed from PV+ starter cells. Briefly, PV-
LSL-tTA mice were injected into mPFC with 100-300 nL of helper virus (AAV2/9-TRE-HTG).
Two weeks later, .5 uL of rabies virus (EnvA-SAD-∆G-mcherry) was injected under conditions
in the mPFC. 5-7 days post-rabies infection mice were sacrificed and perfused for histological
examination. 50 uM sections were cut and imaged with a Zeiss 780 LSM confocal microscope
and images were viewed using ImageJ.
3.2.5 Data analysis
EPSC latency, 20-80% rise-time, half-width, and decay time constant (calculated over 20-80%
of the decay phase) were calculated from either the averaged trace or individual sweeps for each
cell using automated procedures in the AxoGraph X 1.5.4 software. EPSC latency was detected
when the initial slope exceeded a threshold of -2 pA/ms, and IPSC latency was calculated from
the peak of the inward current that preceded the IPSC. For rise-time, half-width, and decay
time constant measurements, IPSCs were detected in the AxoGraph software using a threshold
of 10 pA/ms initial slope. Action potential latencies were detected as the time to peak.
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3.3 Results
3.3.1 PV monosynaptic rabies tracing from mPFC
The results of our Cre-dependent ChR2 evoked IPSC PPR experiments in PV-IRES-Cre and
SST-IRES-Cre mice suggested that GABA release from PV INs is impaired in DISC1 HET
mice. In other cortical regions, PV INs are recruited by the thalamus to mediate feedforward
inhibition and shape the receptive fields and temporal response properties of pyramidal neurons.
GABAergic transmission in PFC has been shown to be important for cognitive tasks like working
memory. Furthermore, in schizophrenia, for which cognitive impairment is a core feature,
GABAergic markers are reduced in PFC. Therefore we were interested in studying a projection
directly recruits PV INs in the mPFC and is relevant to cognition. It was previously reported
that the MD thalamus directly projects to PV INs in the mPFC (Rotaru et al., 2005). The
role of the MD-mPFC circuit in working memory was recently highlighted (Parnaudeau et al.,
2013), suggesting that this could be a particularly interesting circuit with which to probe the
function of mPFC PV INs in the DISC1 HET mice. Therefore we performed Cre-dependent
rabies tracing from PV-Cre starter cells in the mPFC and looked for retrograde labeling in the
MD.
To determine whether PV INs could also mediate feedforward inhibition in the MD-
dACC circuit, we first examined whether MD neurons directly innervate PV INs in the dACC.
To this end, we used a modified rabies virus system that can trace the monosynaptic inputs
onto genetically identified neurons based on (Wall et al., 2010) strategy. Because helper virus
infection depends on expression of the tetracycline trans-activator (tTA; see Methods) in this
system, we used the PV-Cre;Rosa26-stopflox-tTA mice, in which tTA is specifically expressed
in PV neurons. We injected dACC unilaterally in these mice with the helper virus AAV-TRE-
hGFP-TVA-G and two weeks later injected the same location with the rabies-EnvA-SAD-∆G-
mCherry Fig3.3A, for which seven days were allowed to achieve trans-synaptic labeling. In the
mPFC, hGFP+ PV cells, mCherry+ rabies-EnvA-SAD-∆G-infected cells, and cells colabeled
for both hGFP and mCherry were observed Fig3.3B. These hGFP/mCherry double-positive
cells represent the PV starter cells for rabies input tracing. This approach revealed that a sub-
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stantial population of neurons in the central and lateral aspects of the MD, with a few scattered
neurons in the intermediodorsal thalamic nucleus and centrolateral thalamic nucleus, directly
project onto the PV INs of dACC Fig3.3C. Based on the location of the retrogradely labeled
neurons, I targeted my AAV-CAG-ChR2-GFP injections into the corresponding coordinates of
MD: A/P -1.58 mm; M/L -0.44 mm; D/V -3.20 mm. Using these coordinates, I hoped to infect
MD neurons that would likely project to mPFC PV INs.
3.3.2 Anatomical organization of the MD-PFC circuit
I was curious to compare the results of anterograde and retrograde tracing obtained using
our MD stereotaxic coordinates – (modified from (Parnaudeau et al., 2013) – with those of
Matyas et al.. My retrograde CTB results were remarkably consistent with the pattern of CTB
labeling observed in Matyas et al. Fig3.4A-C. CTB-labelled neurons were located primarily in
dACC and ventral orbital (VO) and lateral orbital (LO) cortices in rostral mPFC and almost
exclusively dACC and M2 in caudal mPFC sections Fig3.4C. In contrast, when the midline
thalamic nuclei were injected with CTB, fewer neurons were seen in the VO/LO and labeled
neurons appeared to extend more ventrally along the rostral mPFC. In caudal mPFC sections,
CTB-labelled neurons were located in IL as opposed to dACC Fig3.4D. These results suggest
that, consistent with the results of Matyas et al., focal injections into MD primarily label
neurons in the dorsal portion of mPFC. From CTB injections we also noted that while MD
sends ipsilateral projections to the dACC, there is some degree of crossover in the dACC-MD
pathway Fig3.4C.
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Figure 3.3: mPFC PV rabies tracing reveals dense input from MD. A. EnvA-SAD-∆G-mCherry
was delivered unilaterally into the mPFC of PV-Cre; Rosa-stopflox-tTA mice two weeks post injection
of helper virus (AAV2/9-TRE-HTG) into the same location. B. Top panel: rabies starter virus injection
location, 5 days after rabies virus injection. Boxed region imaged at 20x to right. Middle panel: PV starter
cells colabeled for hGFP and mCherry, indicating that they were infected with both rabies helper virus
and rabies virus, thus rendering rabies competent to transport. C. Retrograde spread of rabies virus
revealed a dense cluster of projection neurons in the central and lateral aspects of the mediodorsal
thalamus (MD).
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Figure 3.4: dACC neurons project to the MD. A. CTB+ projection neurons in cingulate, ventral
orbital and lateral orbital frontal cortex from Matyas et al. 2014. Most posterior section, far right, shows
almost exclusive labeling in cingulate. B. MD CTB injection location that corresponds to panel A. From
left: MD CTB injection in red, vGluT2 in green delineates boundaries between MD and other midline
thalamic nuclei; dmPFC section with parvalbumin (PV) staining in green. Line indicates drop out of
PV labeling in superficial layers. C. From left to right; MD CTB injection in red, ChR2-AAV in green;
CTB+ projection neurons in frontal cortex, note pattern is similar to far left section in panel A; more
posterior section with CTB+ pattern that corresponds with far right section in A. D. Midline thalamic
nuclei (paraventricular nucleus and intermediodorsal nucleus) CTB injection in red, ChR2-AAV in green;
CTB+ neurons in frontal cortex, note CTB doesn’t label VO/LO heavily and extends more ventrally in
mPFC; more posterior section with CTB+ neurons that are localized ventral to cingulate corresponding
to infralimbic cortex.
81
Next, I injected AAV-ChR2-YFP virus into the MD of PV-IRES-Cre; Ai14 mice to
compare the axonal arborizations of MD projection neurons to the dACC/PrL boundary iden-
tified by the drop off of superficial PV+ INs reported in (Matyas et al., 2014). I observed
that ChR2+ MD axons overlapped almost perfectly with the portion of mPFC that displays
superficial PV+ INs Fig3.5. Taken together with the PV rabies and MD CTB tracing, these
results suggest that MD is poised to recruit layer III PV INs to mediate feedforward inhibition
in dACC. The relative lack of superficial PV INs in PrL is intriguing and raises questions about
the role of superficial PV INs in shaping the response properties of dACC as opposed to PrL. In
the future, these chemoarchitectonic markers can serve as a useful tool to differentiate between
the dACC and PrL, which be crucial to understanding their distinct functions.
ChR2 YFP PV Ai14 
MD       ACC 
Merge Merge fluor +1.94
ChR2 YFP PV Ai14 Merge+1.54 Merge fluor 
MD       ACC 
Figure 3.5: MD axons colocalize with superficial PV+ INs in dACC Injection scheme: ChR2
virus was injected unilaterally into MD of PV-IRES-Cre; Ai14 mice. Top and bottom panels, left to right:
ChR2+ MD axons terminate in dorsal mPFC. Red line indicates ventral boundary of MD axon labeling;
PV Ai14 reporter- note the sudden drop in the number of superficial layer PV+ INs corresponding to the
ventral border of MD axon labeling; merged subtraction image of MD axons with PV reporter; merged
fluorescent image. MD ChR2+ axons green; PV-IRES-Cre; Ai14 reporter red.
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3.3.3 Optogenetic activation of MD-dACC circuit
To delineate the functional connectivity between the MD and the dACC, we injected the MD
with the AAV-CAG-ChR2(H134R)-YFP, which expresses the light-sensitive cation channel
channelrhodopsin-2 (ChR2) (Zhang et al., 2006) tagged with the yellow fluorescent protein
(YFP) Fig3.6A,B. We first confirmed that MD axons make functional synapses onto principal
neurons in layer III of mPFC. Layer III neurons in the vicinity of YFP+ puncta were targeted
for recording. We next used blue light pulses (0.5 ms) to stimulate ChR2-expressing axons
originating from MD neurons in acute slices while recording, using whole cell patch-clamp tech-
nique, excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs, respectively) from
layer III pyramidal neurons (PNs) in the dACC Fig3.6C. Photostimulation of MD axons re-
liably elicited both EPSCs and IPSCs in all layer III PNs recorded Fig3.6D, with the onset
latency of the IPSCs being longer than that of the EPSCs (the latency to onset of the MD-
driven EPSCs and IPSCs was 5.48 ± 0.12 ms and 10.24 ± 0.26 ms, respectively) Fig3.6E.
IPSCs were blocked by application of either GABAA receptor antagonist picrotoxin (PTX) or
AMPA/kainate receptor antagonist CNQX Fig3.6F-H, indicating that they are polysynaptic
inhibitory currents.
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Figure 3.6: Optogenetic stimulation of MD axons drives monosynaptic EPSCs and delayed
IPSCs onto layer III pyramidal neurons in dACC. A. AAV-CAG-ChR2(H134R)-YFP was injected
unilaterally into MD. B. 3-4 weeks later, robust YFP signal was observed within the MD and in layers
I, III, and V of the dorsal portion of the mPFC, corresponding to dorsal anterior cingulate cortex
(dACC). C. Layer III pyramidal neurons (PNs) were recorded in whole-cell voltage clamp mode while
MD axons were activated by a brief 0.5 ms 470 nm λ light pulse delivered through a 60x objective.
D. PNs were recorded at EIPSC (-60 mV) and 0 mV. MD axon stimulation elicited a short-latency
monosynaptic inward current followed by a delayed outward current. E. Onset latency of light-evoked
IPSCs was significantly more delayed than that of light-evoked EPSCs (10.25 ± 0.26 ms vs. 5.48 ±
0.12 ms, ***p<0.00001 two sample t-test). F. MD-evoked outward currents, recorded at 0 mV in the
presence of the NMDA receptor antagonist AP-5 were blocked by picrotoxin (PTX), confirming that
they are GABAA mediated. G. AMPA/kainate antagonist CNQX abolished both inward and outward
currents, indicating that MD-evoked IPSCs are polysynaptic in nature. H. Combined quantification of
IPSC suppression following drug application (total of 5 neurons recorded from 5 animals).
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3.3.4 MD-evoked IPSCs are likely disynaptic, mediated by PV INs
In complex circuits, each synapse that contributes to a response increases the latency and jitter
of the response onset. To determine if the inhibition recruited by MD axon stimulation was
mainly disynaptic or polysynaptic, we compared the onset latency of IPSCs (10% rise time)
evoked at either low probability (>50% failure rate) or high probability (0% failure rate) within
the same neurons Fig3.7A. Using “minimal” stimulation, we sought to isolate thalamically-
driven IPSCs by avoiding polysynaptic excitation. We found that the latency to onset for
reliably-evoked IPSCs was significantly shorter than for minimally-evoked IPSCs (reliable, 11.0
± 0.45; minimal, 13.25 ± 0.46; **p<0.005 F(1, 8) = 19.03 one-way repeated measures ANOVA
n=9) Fig3.7B. The fact that the latency of MD-evoked IPSCs decreased as IPSC amplitude
increased argues against the idea that increasingly recruited polsynaptic activity drove the
IPSC. The IPSC latencies are rather long compared to what has recently been reported using
optogenetic stimulation (Cho et al., 2013), but several main factors likely contribute to this:
1) recordings were performed at room temperature and 2) short duration, low intensity light
stimulation was used 3) IPSCs were not recorded at EEPSC. Recordings were performed at 0
mV, where we observed an inward current that preceded the outward current, and it is possible
that the inward current masked the true onset of the IPSC. However, while the onset jitter of
the EPSCs was significantly smaller than that of MD-driven IPSCs onto PNs (EPSC, 0.24 ±
0.03, IPSC 0.38 ± 0.04; Z = 3.33, ***p<0.001, Wilcoxon signed ranks test) Fig3.7C, as would
be expected for monosynaptic versus disynaptic responses, the jitter of the MD-driven IPSCs
in PNs is similar to what has been previously reported for disynaptic inhibition (Kanichay &
Silver, 2008). This result suggests that inputs from MD drive disynaptic feedforward inhibition
onto layer III PNs in the dACC.
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Figure 3.7: MD-evoked IPSCs are likely disynaptic. A. Sample trace from layer 3 PN in which
low stimulation was used to evoke MD-driven IPSCs with low probability (<50%, in gray). Stimulation
intensity was then increased until IPSCs exhibited 100% reliable responses (black). B. Reliably-evoked
IPSCs exhibited significantly shorter onset latencies compared to minimal IPSCs, measured from the
onset of light stimulation to 10% rise time (**p<0.005 one-way repeated measures ANOVA). C. MD-
evoked IPSCs exhibit sub-millisecond onset jitter that is significantly higher than the jitter of MD-evoked
EPSCs (***p<0.001, Wilcoxon signed ranks test).
Given that we had previously observed that PV- and SST-evoked IPSCs exhibit distinct
decay kinetics (Chapter 1), we compared the kinetics of MD-evoked IPSCs to direct light-evoked
IPSCs from PV INs, using the same stimulation and recording parameters Fig3.8A. We found
that the kinetics of the MD-driven feedforward IPSCs in dACC PNs were similar to that of
IPSCs in these neurons evoked by direct photostimulation of local PV INs Fig3.8B-C (rise
time: feedforward IPSCs, 2.17 ± 0.18, n = 14; PV-evoked, 1.76 ± 0.31 ms, n = 5; p>0.05,
t-test; decay time: feedforward IPSCs, 29.09 ± 1.27 ms, n = 14; PV-evoked, 31.22 ± 2.12 ms,
n = 5; t(7.08) = 0.86, p>0.05, t-test).
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Figure 3.8: Feedforward IPSCs resemble IPSCs directly mediated by PV INs A. Left: AAV-
DIO-ChR2-YFP was expressed in PV INs in dACC, and layer 3 PNs were recorded at 0 mV in whole-
cell voltage-clamp mode while PV axons were activated using the same stimulation protocol as in MD
activation experiments. Right: time-aligned, normalized sample traces of IPSCs recorded in response
to MD axon stimulation (black dashed line) or direct PV ChR2 activation (in green). B. Feedforward
IPSCs exhibited similar rise time as PV-evoked IPSCs (rise time: feedforward IPSCs, 2.17 ± 0.18 ms,
n = 14; PV-evoked, 1.76 ± 0.31 ms, n = 5; p>0.05, two sample t-test). C. Feedforward and local PV-
evoked IPSCs exhibited very similar 80-20% decay times (feedforward IPSCs, 29.09 ± 1.27 ms, n = 14;
PV-evoked, 31.22 ± 2.12 ms, n = 5; t(7.08) = 0.86, p>0.05, two sample t-test).
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3.3.5 Thalamocortical transmission onto PV INs and PNs
To determine the functional connectivity between MD neurons and PV INs in the dACC, we
injected MD with the AAV-CAG-ChR2(H134R)-YFP at the location determined by rabies
tracing that project to dACC PV INs Fig3.9A. We used the PV-Cre;Ai14 mice, in which PV
INs in the mPFC are readily identified on the basis of their red fluorescence. In order to confirm
that L3 PV INs in dACC receive direct excitatory input from the MD, we recorded EPSCs in
PV INs, as well as neighboring PNs in dACC (<50 µm apart), in response to photostimulation
of MD axon fibers expressing ChR2 Fig3.9B-C. Robust EPSCs were readily recorded from
both PV INs and PNs, with the EPSC rise-time of PV INs being significantly faster than that
of PNs (PV, 1.22 ± 0.14 ms; PN, 2.21 ± 0.15 ms; **p<0.005 t= 3.89 DF= 8 paired sample
t-test) Fig3.9D-E. The faster EPSC rise-time of PV INs resulted in these neurons reaching
peak EPSC amplitude earlier than neighboring PNs (PV INs, 7.7 ± 0.4 ms; PNs, 11.1 ± 0.4 ms;
***p<0.0005 paired t-test t= 8.03 DF= 8), suggesting that MD inputs are capable of evoking
action potentials in PV INs within a time frame during which they can shape network activity
driven by thalamocortical excitation. These results demonstrate that layer III PV INs in the
dACC receive direct excitatory inputs from the MD, and raise the possibility that these PV
INs mediate MD-driven feedforward inhibition in the dACC.
Next, we compared the synaptic and cellular properties of layer III PV INs with those of
PNs in the dACC using the WT PV-Cre; Ai14 mice. Surprisingly, we found that the amplitude
of EPSCs onto PV INs was not significantly larger than that onto neighboring PNs in the dACC
in response to photostimulation of axons originating from the MD (PV INs, 167.2 ± 30.0 pA;
PNs, 113.7 ± 48.8 pA; p= 0.10 t= -1.84 DF= 8 paired sample t-test) Fig3.9F. In addition,
the MD-driven EPSCs onto both cell-types showed strong pair-pulse depression (100 ms inter-
pulse interval), indicating high presynaptic release probability (PN, 0.54 ± 0.05; PV, 0.52 ±
0.04 p>0.05 t=0.32 DF= 25.82 two sample t-test) Fig3.9G. These results differ from findings
in the sensory cortices, where thalamic drive onto fast-spiking INs (presumptive PV INs) is
much stronger and shows a higher degree of pair-pulse depression than synapses onto layer IV
principle neurons (Beierlein et al., 2003; Cruikshank et al., 2007; Gabernet et al., 2005).
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Both PV INs and PNs in the dACC received MD-driven feedforward inhibition, which
showed strong pair-pulse depression (100 ms inter-pulse interval) (PNs, 0.07 ± 0.02, n = 13; PV
INs, 0.15 ± 0.07, n = 6, p>0.05 t= -1.16 DF= 5.67) Fig3.9H. These results are consistent with
sensory thalamocortical transmission, whereby feedforward inhibition decreases dramatically
during repeated stimulation, thus increasing the integration window in thalamorecipient neurons
in the cortex (Gabernet et al., 2005).
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Figure 3.9: MD directly activates PV interneurons in layer 3 dACC A. PV-Cre;Ai14 mice were
injected into MD with 0.3 uL AAV-CAG-ChR2-YFP. B. 3 weeks later high expression was observed in
MD axons terminating in layers I, III, and V in dACC. PV and PNs in the vicinity of GFP+ puncta
within layer 3 were targeted for recording. Note the marked drop off in superficial Tdtomato+ PV
INs ventral to the region of mPFC labeled by YFP+ MD axons. C,D. MD light-evoked responses were
sequentially recorded in neighboring PV and PNs in dACC (<50 µm apart). E. EPSC rise times were
significantly faster in PV INs compared to the EPSC rise times in PNs (**p<0.005 paired sample t-
test). F. There was no significant difference in MD-evoked EPSC amplitude onto neighboring PV vs.
pyramidal neurons (p= 0.10 paired sample t-test). G. PPR of MD-evoked EPSCs onto PV INs and PNs
was equal across a 100 ms interval (p>0.05 two sample t-test). H. PV INs that receive monosynaptic
excitatory input from MD also receive feedforward inhibition. MD-evoked IPSCs onto PV INs and PNs
are strongly depressing at 100 ms stimulation interval (PN, 0.07 ± 0.02; PV, 0.15 ± 0.07 p>0.05 t=
-1.16 DF= 5.67 two sample t-test).
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In order to compare the level of inhibition produced by PV INs in the MD-dACC
pathway in WT vs. DISC1 HET mice, we first tested whether glutamatergic transmission onto
PV INs from the MD was similar across DISC1 HET and WT mice. Otherwise, within the
disynaptic circuit, it is difficult to interpret whether a reduction in feedforward inhibition is
due to altered GABA release or reduced thalamic drive onto PV INs. Preliminary data were
collected using Cs-internal solution, and later recordings were made using K-gluconate internal
+ QX-314. Here, I’ve combined preliminary Cs- and later K-gluconate internal data for paired
PV/PN recordings. I first performed sequential recordings of neighboring PV INs (identified
by tdTomato) and PNs. A property of thalamocortical circuits in sensory systems is the robust
activation of fast-spiking PV INs that mediate feedforward inhibition (Cruikshank et al., 2007).
PV INs respond more strongly to TC excitatory input than local pyramidal neurons due to
the strength of TC synaptic inputs and not due to differences in intrinsic membrane properties
(Cruikshank et al., 2007). In order to compare the ratio of direct MD thalamocortical excitation
onto PV INs vs. PNs I calculated the following:
peak PV AMPA − peak PN AMPA
peak PV AMPA + peak PN AMPA
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I found that the MD-evoked AMPA current was greater onto PV INs compared to
PNs in both WT and DISC1 HET mice (WT, 0.33 ± 0.09 HET, 0.26 ± 0.08 p= 0.61 two-
tailed t-test) Fig3.10A-B. While this data suggests that the ratio of excitation onto PV INs
vs. PNs is consistent across genotypes, we cannot determine if the absolute amount of MD-
mPFC excitatory transmission is the same. I next recorded MD-evoked AMPA and NMDA
currents in the presence of PTX (100 uM) onto PV+ INs and PNs within the same PFC slices.
In the presence of PTX, brief (0.5 ms), low intensity light stimulation recruited substantial
recurrent excitatory input onto the recorded cells, particularly the PV INs. Consequently,
very low intensity light stimulation was used to avoid the generation of epileptiform activity.
The mPFC is known to exhibit high reciprocal connectivity among neurons in comparison to
sensory cortex (Mason et al., 1991; Schwindel et al., 2014; Wang et al., 2006). This may explain
why it was difficult to isolate light-evoked monosynaptic excitatory currents in the presence of
PTX; it appears that intact feedforward inhibition suppresses recurrent excitation in response
to incoming thalamocortical input. A two-way ANOVA revealed that there was a main effect
of cell type but no significant effect of genotype or the interaction of genotype with cell type
on the % AMPA transmission (cell type F(1, 33)= 23.78, ****p<0.0001 genotype F(1, 33)=
0.95, p= .34, interaction F(1, 33)= 1.09, p= 0.30). AMPA% was significantly higher in PV
INs vs. PNs for both genotypes (WT and HET **p<0.01, Tukey’s multiple comparisons)
Fig3.10C-D.
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Figure 3.10: Unaltered response properties of PN/PV neurons in DISC1 compared to WT
mice. A. Recording configuration. B. PV INs on average responded more strongly to MD input than
neighboring PNs. WT and DISC1 HET mice do not show a significant difference in relative PV response
strength. Blue circles indicate K-gluconate internal recordings as opposed to Cs. C-D. PNs exhibit
significantly higher NMDA component at the MD-dACC synapse compared to PV INs ***p<0.001
two-tailed t-test
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3.3.6 Relative timing of MD-evoked EPSCs and IPSCs
I next compared MD-evoked IPSC and EPSC rise-times between DISC1 HET and WT mice.
The 20-80% rise-times for light-evoked IPSCs were (WT, 2.46 ± .12 HET, 2.33 ± .17 p= 0.59,
two-tailed t-test). The 20-80% rise-times for MD-evoked EPSCs were slightly faster (WT, 2.15
± 0.09 HET, 2.19 ± 0.12 p= 0.77, two-tailed t-test). In polysynaptic circuits, each additional
synapse that contributes to a response increases the latency and jitter of the onset. We therefore
compared the jitter (SD across trials) of latency to the 10% rise time for IPSCs and EPSCs
recorded at the same stimulation intensity. As predicted, the jitter for EPSC onset was low in
WT and DISC1 HET mice (WT, 0.24 ±0.03 HET, 0.24 ± 0.02 ms p= 0.88, Mann-Whitney)
Fig3.11A. While the jitter was larger for MD-evoked IPSCs, all cells exhibited jitter <1 ms
with a mean jitter of 0.39 ± .03 ms in WT mice and 0.47 ± 0.05 ms in HET mice (p= 0.22,
two-tailed t-test). In both genotypes, IPSC onset had a significantly higher jitter than EPSC
onset (WT, **p<0.01 Wilcoxon signed ranks test HET, ***p<0.001, paired two-tailed t-test)
Fig3.11A. This is to be expected, as the disynaptic IPSC jitter is additionally affected by IN
spike jitter and the jitter of IN-PN transmission. The low IPSC onset jitter we observed suggests
that trial to trial, IPSCs are time-locked to the stimulus, consistent with disynaptic as opposed
to polysynaptic inhibition Fig3.11B (Kanichay & Silver, 2008; Torborg et al., 2011).
We next looked at the relative timing of the EPSCs and IPSCs evoked by MD light
stimulation in DISC1 WT and HET mice. We compared the respective 10% rise time points to
determine the EPSC-IPSC delay (based on (Mittmann et al., 2005)). Comparing the 10% rise
time point more accurately reflects the overlap of EPSC and IPSC currents than peak offset,
as peak times are affected by varying EPSC and IPSC rise times. We found that mean delay
between EPSC and IPSC onset was 4.7 ± 0.26 in WT and 5.5 ± 0.26 in HET mice Fig3.11C.
This delay is longer than what has been reported in other studies of feedforward inhibition
(Cho et al., 2013; Cruikshank et al., 2007; Mittmann et al., 2005) but it may be that the IPSC
onset is delayed by the inward current. In fact, we noted that one neuron that exhibited a more
typical delay of 1.7 ms also didn’t display any inward current at 0 mV. This hypothesis can
easily be tested by recording IPSCs at 0 mV and the experimentally-determined EPSC reversal
potential to compare the onset latency. Comparison of WT and HET mice showed that there
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was a small but significant increase in the EPSC-IPSC delay in DISC1 HET mice (*p<0.05,
two-tailed t-test).
Photostimulation of MD afferents occasionally resulted in IPSCs onto layer III pyrami-
dal neurons that exhibited two distinct peaks Fig3.11D. This second peak could come from
polysynaptic input or from PV INs firing more than one action potential in response to light
stimulation (which we have observed). Pooling double-peak traces from 21 neurons in 13 mice,
the mean latency to the first peak was calculated to be 14.78 ± .50 ms while the latency to
the second peak was 20.47 ± .83 ms Fig3.11D. From this data we restricted our assessment
of feedforward inhibition to averaged IPSC traces whose peaks occurred within 19 ms after
stimulation onset. This data was then used to compare GABA: AMPA ratios of MD-evoked
synaptic transmission onto layer III PNs in DISC1 WT and HET mice. Because we compared
peak current amplitudes as opposed to charge transfer, I did not sort data based on other
measures such as the IPSC decay time constant. However, we observed that the IPSC decay
time constant remained consistent across increasing stimulation intensity, arguing against the
substantial recruitment of feedback inhibition.
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Figure 3.11: MD-evoked IPSCs onset consistent with disynaptic inhibition. A. Light-evoked
IPSCs display onset latency jitter (S.D. of onset to 10% rise time) that is significantly higher than EPSC
jitter but still time-locked to the stimulus in both WT and HET mice (n= 23, 19). B. Sample traces of
sequentially recorded IPSC sweeps in WT; onset jitter= 0.40. C. Inhibitory and excitatory MD-evoked
synaptic currents were separated by voltage clamping at EIPSC (-60 mV) and 0 mV (not equal to the
AMPA reversal potential). The peak amplitudes were measured and the 10% rise time point calculated
for EPSCs and IPSCs in DISC1 WT and HET mice (sample neurons, marked by red bar). For each
recorded neuron, the EPSC 10% rise time point was subtracted from the IPSC 10% rise time point to
calculate the delay (WT, 4.7 ± 0.26 HET, 5.5 ± 0.26 p<0.05 two-tailed t-test. Note that 10% rise time
points slightly precede or coincide with the peak of the EPSC. D. While IPSC onset jitter and rise time
had low variability, sometimes clear double peaks were observed in the trace. The mean latency of the
first compared to second peak was 14.78 ± .50 ms vs. 20.47 ± .83 ms (n= 21 neurons, pooled from 13
animals WT and HET). Based on this delayed peak, we restricted our feedforward IPSC comparison to
averaged traces with a peak latency <19 ms. ** p<0.01, *** p<0.001
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In my MD-evoked IPSC recordings, I took special care to distinguish whether I was
recording disynaptic IPSCs that were mediated by INs directly activated by MD axons, or
polysynaptic IPSCs that were mediated by INs that were activated by local PNs Fig3.12A.
I considered the relevant steps required to initiate the IPSC, from photostimulation, to EPSC
onset, PV AP peak, and IPSC onset. Given that the mean IPSC latency to onset was 9.46
ms (calculated from inflection point from inward to outward current) and the mean PV AP
peak time was 7.8 ms, the estimated PV-PN synaptic latency would be ∼1.6 ms. This value
is consistent with the 1-2 ms range for PV-PN synaptic latencies observed in the hippocampus
(Hefft & Jonas, 2005) and mPFC Fig3.12B (Cardin et al., 2009; Gao et al., 2003; Gonza´lez-
burgos et al., 2005). This observation alone does not support the idea that PV INs mediate
disynaptic inhibition, but it demonstrates that PV INs spike with a latency that is consistent
with the onset of the MD-evoked IPSC. Rarely, neurons were recorded that did not exhibit
any clear feedforward inhibitory currents Fig3.12C. By comparing these traces to those of
typical MD-evoked IPSCs, one can see that these late IPSCs have variable onset times, exhibit
multiple peaks, and have slower decay kinetics, suggesting that they may correspond to feedback
inhibition recruited by another IN subtype. While this data alone does not support the model
that MD-evoked IPSCs are disynaptic, low IPSC onset jitter lends support.
97
Photostimulation
ChR2 activation in axon terminals
Axon depolarization
Glutamate release at axon terminals
 
4.
6 
m
s
EPSC onset 
AP peak in PV interneuron
 ~
7.
8 
m
s
~9
.4
 m
s
IPSC onset
IN
MD PN
excitatory
inhibitory
1 2
Feedforward
MD PN
IN
1
2
3
mPFC mPFC
FeedbackA.
B. C.
10 ms
10 ms1
00
 p
A
10
0 
pA
Figure 3.12: MD-evoked IPSC latency is consistent with disynaptic feedforward inhibition.
A. Circuit diagrams describe the disynaptic route of feedforward inhibition versus the tri- or polysynaptic
route of feedback inhibition. PN, layer III pyramidal neuron and IN, presumptive PV interneurons. B.
Sequence of events required to generate disynaptic IPSCs in the MD-dACC pathway, latencies derived
from electrophysiological recordings. C. Top trace: clearly delayed feedback inhibition in the absence of
feedforward inhibition. Note the variable onset and slow decay of the IPSCs. Bottom: neuron recorded
in the same mouse that exhibits typical disynaptic inhibitory currents. Note low jitter of onset and rapid
decay kinetics. Figures A. and B. adapted from supplementary figures in (Cho et al., 2013)
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3.3.7 Chemicogenetic inhibition of PV+ interneurons during MD axon stim-
ulation
In order to confirm that PV interneurons are in fact the main mediators of feedforward inhibition
from the MD, I carried out a series of experiments to selectively suppress PV+ interneuron
response to MD axon stimulation while recording evoked inhibitory currents onto layer III
PNs. The first approach utilized the DREADD (designer receptor exclusively activated by
designer drug) system (Rogan & Roth, 2011). The inhibitory DREADD is a modified G-
protein coupled receptor that decreases neuronal activity by inducing an inward rectifying
potassium current response when bound by the exogenous ligand clozapine-N-oxide (CNO)
(Armbruster et al., 2007). I took advantage of Cre-dependent inhibitory DREADD virus AAV-
DIO-hM4Di-mCherry to selectively express the DREADD receptor in PV INs of PV-IRES-Cre
mice. I injected 1 uL of AAV-DIO-hM4Di-mCherry bilaterally into mPFC and injected the MD
bilaterally with 0.3 uL of AAV-CAG-ChR2-YFP per hemisphere.
Layer III mPFC pyramidal neurons were patched and MD-evoked IPSCs recorded for
2-6 minutes to establish a baseline response prior to washing on 10 uM of CNO Fig3.13A.
“After CNO” IPSCs were measured 8-10 minutes after CNO was applied. I observed that up
to 30 minutes of CNO washout did not cause appreciable recovery of the IPSC, and therefore
one cell was recorded per section. Of the 6 neurons recorded from two animals, 5 exhibited
CNO suppression of MD-evoked IPSCs Fig3.13B. Among the neurons that were affected by
CNO bath application, the percent IPSC suppression was 89.1 ± .05. When all 6 cells were
considered, CNO still significantly reduced the amplitude of the MD-evoked IPSC (*p<.05,
Wilcoxon signed ranks test). It is possible that the pyramidal neuron that was unaffected by
CNO application was not targeted by hM4Di-infected PV INs. To that end, I noticed that the
densest hM4Di infection was in the ventral portion of the mPFC that did not overlap with the
MD ChR2 YFP+ axons in both animals Fig3.13C. I injected a large volume (1 uL) in order
to infect the maximum number of PV INs possible, and the virus likely spread. Regardless, the
effect CNO had on MD-evoked IPSCs in PrL/dACC layer III PNs was striking considering the
small number of local infected PV INs.
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It bears mentioning that the IPSC peaks compared before and after CNO were the first
peak in occasionally complex IPSCs. Interestingly, CNO had different effects on the early and
late components of the IPSC. Fig3.13D is a sample trace of a pyramidal neuron that exhibited
a short latency single IPSC peak (latency 14.8 ± .53 ms (SD)) and exhibited rapid suppression
of the evoked IPSC following CNO application Fig3.13E. CNO also induced a significant shift
in the time of peak Fig3.13F (F(1, 16) = 49.0, ****p<0.0001, one-way ANOVA). Fig3.13G
is an example cell that exhibited two IPSC peaks separated by ∼14 ms. Intriguingly, CNO
rapidly suppressed the short latency (∼16 ms) IPSC peak and enhanced the late (∼30 ms)
IPSC peak but did not affect MD-evoked EPSCs Fig3.13G,H. The early IPSC peak latency
was not altered by CNO, while the late peak latency was significantly shifted forward in time
(early: F(1, 33) = 1.33, p = 0.26; late: F(1, 33) = 62.1, ****p<0.0001 one-way ANOVA)
Fig3.13I.
Given the small number of cells and mixture of responses, the PV DREADD results
are more exploratory than conclusive. However, this experiment did uncover a potential link
between the latency of the MD-evoked IPSC peak and the inhibitory cell-type of origin. The PV
DREADD suppression results suggest that short latency (<19 ms) IPSCs are mediated by PV+
INs, while longer delay IPSCs (≥30 ms) are mediated by a different population of inhibitory
INs. The opposite effect of CNO on the early and late IPSC components in Fig3.13G suggests
that the late IPSC represents feedback inhibition. It’s tempting to speculate that feedback
inhibition gets increasingly recruited as feedforward inhibition is reduced, allowing pyramidal
neurons to reach threshold and spike in response to MD stimulation. This experiment suggests
that the recruitment of feedforward vs. feedback inhibition is sensitive to stimulation intensity,
therefore I set my stimulation to the maximum intensity that evoked a single, short-latency
IPSC peak in subsequent E/I experiments. Two major limitations of the DREADD approach
were 1) it is low-throughput: only one cell could be recorded per slice, and total recording
time including wash on and off was nearly 45 minutes 2) the CNO effect was relatively slow
and not reversible over the time course I recorded. Therefore, given its temporal precision
and reversibility, optogenetic silencing of PV interneurons was a more attractive option moving
forward.
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Figure 3.13: Chemicogenetic inhibition of PV+ interneurons during MD axon stimulation. A.
Recording configuration. B. CNO significantly reduced MD-evoked IPSC amplitude (p<0.05, Wilcoxon
signed ranks test n= 6, 2). Data points represent 30 traces averaged immediately prior to CNO appli-
cation and 8-10 minutes after application (box plots 25, 75 percentile). C. mPFC section imaged after
recording shows ChR2+ axon labeling and distribution of hM4Di expression at 5x and 20x magnifica-
tion. D. Sample cell with single IPSC peak; black before CNO, red after CNO. E. CNO induced rapid
suppression of IPSC. Each data point is the average of 10 trials. F. CNO caused a slight but significant
shift in the IPSC peak latency (****p<.0001, one-way ANOVA). G. Sample cell with complex, double
IPSC peak. H. CNO induced rapid suppression of first peak and enhanced the second peak. I. CNO
significantly increased the latency to peak of the second IPSC peak but not the first (****p<.0001,
one-way ANOVA).
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3.3.8 Optogenetic silencing of PV+ interneurons during MD axon stimula-
tion
To directly test the hypothesis that these PV INs mediate the MD-driven feedforward inhibi-
tion, we sought to inhibit these neurons while monitoring the MD-driven synaptic responses
in dACC PNs. To achieve this goal, we first injected the MD of the PV-Cre mice with AAV-
CAG-ChR2(H134R)-YFP, and subsequently injected the dACC in the same mice with pAAV-
Ef1a-DIO-eNpHR3.0-mCherry that expresses the light-gated chloride pump halorhodopsin (eN-
pHR3.0) in a Cre-dependent manner and can suppress neuronal firing in response to red light
(Gradinaru et al., 2010) Fig3.14A. We verified that activation of eNpHR3.0 reversibly inhib-
ited PV IN firing Fig3.14B via its potent hyperpolarization (41.9 ± 4.8 mV hyperpolarization,
n=5) Fig3.14C. Inhibition of PV INs dramatically reduced, and in some cases abolished, the
MD-driven feedforward inhibitory currents in layer III PNs, measured at either 0 mV or -30
mV holding potential (0 mV ***p<0.001 W= -66.00 Wilcoxon matched-pairs signed-rank test)
Fig3.14D-E) and this effect was reversible upon the cessation of the red light illumination
(F(1.232, 4.93) = 29.88, **p<0.01, one-way repeated measures ANOVA; Tukey’s post-hoc test,
*p<0.05; **p<0.01) Fig3.14F. Interestingly, inhibition of PV INs prolonged the MD-driven
EPSCs in PNs recorded at -30 mV holding potential, as measured by the EPSC half-width
(***p<0.001, paired t-test) Fig3.14G. In contrast, the peak amplitude of the MD-driven
EPSC at -30 mV was not altered by PV IN inhibition (red LED off, -129.40 ± 26.12 pA;
red LED on, -122.25 ± 30.04 pA, W= -17.0, p>0.05, Wilcoxon matched-pairs signed rank test)
Fig3.14H.
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Figure 3.14: Optogenetic silencing of PV+ INs during MD axon stimulation. A. 470 nm λ
light was used to excite MD axons while simultaneously 625 nm λ light was used to activate NpHr3.0
and silence PV INs. Red LEDs were triggered 5 ms prior to the onset of the 0.5 ms blue light pulse and
illuminated for a total of 20 ms. B. Cell-attached recordings from GFP+ eNpHR3.0-infected PV INs
revealed short-latency spikes with low jitter following ChR2 activation (latency to peak= 5.46 ± 0.13
ms, jitter (S.D.) = 0.36 ± 0.09 n=3) that were reversibly blocked by concurrent red LED stimulation
(indicated by red shading). C. Red LED stim. hyperpolarized GFP+ PV INs. Inset: 500 ms blue light
pulse drove fast spiking in eNpHR3.0+ PV IN. D. Sample trace: red LED stim. reversibly suppressed
ChR2-evoked IPSCs onto layer III PNs recorded at 0 mV or -30 mV. E. Peak IPSC amplitude recorded
at 0 mV was significantly reduced by red LED stim. F. Silencing PV+ INs reversibly reduced MD-
evoked IPSC amplitude. G. eNpHR3.0 activation prolonged ChR2+ evoked inward excitatory currents
recorded at -30 mV, as measured by the EPSC half-width. H. red LED stim. did not affect EPSC peak
amplitude recorded at -30 mV (p>0.05, Wilcoxon matched-pairs signed rank test). *p<0.05, **p<0.01,
***p<0.001. N=5
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3.3.9 Suppressing SST interneurons while stimulating MD terminals
To determine whether the somatostatin (SST) neurons, another major class of inhibitory in-
terneurons, also contribute to the MD-driven feedforward inhibition in the dACC, we repeated
the above halorhodopsin inactivation experiment with the exception that SST INs, not PV
INs, were inhibited. For this purpose we used the SST-Cre mice, in which Cre is expressed
under the endogenous SST promoter (Taniguchi et al., 2011) Fig3.15A. Although activa-
tion of eNpHR3.0 effectively suppressed SST INs in the dACC Fig3.15B and induced potent
hyperpolarization (67.25 ± 12.36 mV hyperpolarization, n=5) Fig3.15C, it did not reduce
the MD-driven feedforward inhibition onto L3 PNs Fig3.15D; rather, feedforward inhibition
was enhanced (F(21.554, 12.43) = 32.23, ***p<0.0001, one-way repeated measures ANOVA;
Tukey’s post-hoc test, ***p<0.001) Fig3.15E. Surprisingly, IPSC amplitude remained higher
than baseline even after the red LEDs were turned off (***p<0.001 Tukey’s post-hoc compari-
son) Fig3.15F. Unlike during PV IN inactivation, we found no change in the EPSC half-width
when SST INs were silenced (red LED off, 2.87 ± 0.27 ms; red LED on, 2.72 ± 0.25 ms, t(5)
= 1.79, p>0.05, paired t-test) Fig3.15F.
The MD-driven spiking of PV INs had significantly shorter latencies than that of SST
INs and exhibited a trend towards lower spike jitter (latency to peak: PV, 5.46 ± 0.13 ms, n
= 3, SST, 18.99 ± 1.77 ms, n = 4, t = 7.64, df = 3.03, **p<0.01, t-test; jitter: PV, 0.36 ±
0.09, n=3, SST, 2.29 ± 0.72 ms, n = 4, t = 2.67, df = 3.09, p = 0.07, t-test) Fig3.15G. These
results suggest that the MD-driven, SST IN-mediated inhibition in the dACC is polysynaptic
in nature.
Together, these results indicate that the majority of MD-driven disynaptic feedforward
inhibition in dACC layer III PNs is mediated by PV INs. Removal of PV-mediated inhibition
increased the duration of EPSCs in layer III PNs, presumably increasing the window of time
during which PNs are capable of integrating excitatory inputs. Interestingly, we did not observe
an increase in the peak amplitude of MD-driven EPSCs in the PNs when PV INs were inhibited
(Fig3.14H), consistent with a model in which MD-driven feedforward inhibition limits the
time-course rather than amplitude of excitatory thalamocortical transmission.
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Figure 3.15: Optogenetic silencing of SST+ INs during MD axon stimulation A. DIO-eNphR3.0
virus was injected into mPFC of SST-Cre mice to inactivate SST INs during MD axon stimulation. B.
ChR2 activation drove spiking in 4/6 GFP+ SST INs recorded: latency to spike peak = 18.99 ± 1.77 ms,
jitter (S.D.) = 2.29 ± 0.72 ms (n=4) and was inhibited by red LED stimulation. C. Red LED stimulation
caused on average 67.25 ± 12.36 mV hyperpolarization in GFP+ SOM INs recorded (n=5). D. Sample
trace showing the effect of SST IN silencing on MD-evoked IPSCs. E. Red LED stim. significantly altered
the magnitude of MD-evoked IPSCs onto layer III PNs, increasing MD-evoked IPSC amplitude. IPSC
amplitude remained higher than baseline even after LEDs were turned off. F. SST IN inactivation did
not affect EPSC half-width recorded at -30 mV. G. Top: MD-evoked spiking in PV INs exhibited much
shorter latency than spikes in SST INs (latency to peak: 5.46 ± 0.13 ms, n = 3, SST, 18.99 ± 1.77 ms, n
= 4. Bottom: PV spikes exhibited slightly lower jitter than SST spikes but this did not reach significance
(jitter: PV, 0.36 ± 0.09, n=3, SST, 2.29 ± 0.72 ms, n = 4, p= 0.07, t-test). **p<0.01 ***p<0.001
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3.3.10 PV halorhodopsin effect on PN PSPs
DIO-eNpHR3.0 viral injections into PV-IRES-Cre and SST-IRES-Cre mice Fig. 3.16A,B
both resulted in high levels of eNpHR3.0 expression in PV+ or SST+ INs, respectively Fig.
3.16C-F. In addition, at least one DIO-eNpHR3.0-GFP+ INs was recorded per slice to ensure
sufficient red LED-induced hyperpolarization prior to recording MD-evoked IPSCs. Therefore,
it’s unlikely the dramatically different effects of PV+ vs. SST+ IN silencing can be attributed
to differences in halorhodopsin expression. Feedforward inhibition would serve to sharpen
responses to thalamic input; it has been shown that GABAA blockers prolongs evoked EPSPs,
as measured by increased decay time constant and PSP half-width (Chittajallu & Isaac, 2010;
Lee et al., 2014; Mittmann et al., 2005). Therefore, we performed preliminary recordings to
assess the role of PV INs in controlling PSP half-width of pyramidal neurons. In three neurons
that could be held in current clamp at a stable resting potential across trials of “halo off”
“halo on” “halo off” we observed that red LED stimulation reversibly increased the decay time
constant of the MD-evoked PSP Fig. 3.17A,B. In 1 of the 3 neurons, we saw the neuron
reached threshold when the red LED was turned on 5 ms prior to blue light stimulation and
remained on for 20 ms total. When the red LED was turned off again, the neuron’s responses
returned to subthreshold.
106
MHb
LHb
PVT
MD
PVT
MHb LHb
MD
A B
C D
E F
PV-CRE SST-CRE
Figure 3.16: Halorhodopsin expression. A, B. Sample images of ChR2 injection location in a PV-IRES-
Cre and a SST-IRES-Cre mouse, respectively. C. 5x image of an acute slice from a PV-IRES-Cre mouse
after recording; DIO-eNpHR3.0-GFP+ neurons in green. D. 20x magnification of white box from C. D.
5x image of acute slice from a SST-IRES-Cre mouse after recording; note that there was substantial
photobleaching. F. 20x magnification of white box from D.
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Figure 3.17: Optogenetic silencing of PV+ INs increases MD-evoked PSP duration. A. Sample traces
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PSP, for the middle panel red LED was turned on 5 ms prior to blue light for a total duration of 20
ms. For middle panel subthreshold PSPs were averaged. Right panel: same neuron recorded at same
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with PV IN silencing. Preliminary data (n=3).
3.3.11 E/I balance in the MD-mPFC pathway
Excitation to inhibition (E/I) balance is believed to be important for the fidelity of information
transfer in the cortex. Elevating EI balance by either optogenetically stimulating principal
neurons or silencing PV INs in the mPFC impaired conditioned fear learning and caused social
behavior deficits in mice (Yizhar et al., 2011). Notably, Yizhar et al. reported that modulating
the activity of even a sparse population of PV+ INs had a profound effect on unit activity
in mPFC. This suggests that a small number of PV INs can largely influence mPFC circuit
function. Recent work also supports the idea that PV INs are the main determinant of E/I
balance in the cortex (Xue et al., 2014).
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Given that we observed that PV INs receive monosynaptic excitatory input from the
MD and exhibit larger magnitude responses than neighboring PNs, we hypothesized that short
latency IPSCs evoked by MD axon stimulation are mediated by PV INs. In addition, we
previously observed increased PPR of PV-mediated IPSCs in the DISC1 HET mice. Therefore,
we predicted that if PV INs are the main mediators of feedforward inhibition from the MD, in the
DISC1 HET mice we would see an increase in the excitation/inhibition ratio of synaptic input
driven by the MD-mPFC pathway. Therefore, we measured the ratio of excitatory current to
inhibitory current onto pyramidal neurons evoked by MD axon stimulation in the mPFC.
We found that while the total current (GABA+AMPA) evoked by MD stimulation
onto dACC PNs was consistent between DISC1 HET and WT mice (p= .41, two-tailed t-
test), the GABA contribution was significantly reduced in the DISC1 HET mice (**p<0.01
two-tailed t-test) Fig3.18A,B. The mean GABA:AMPA ratio in WT mice was 2.65 ± .30
vs. 1.56 ± 0.26 in DISC1 het mice (**p<0.01 two-tailed t-test) Fig3.18C,D. The cumulative
probability distributions for DISC1 HET and WT mice were significantly different for IPSC
peak amplitudes but not ESPC amplitudes (*p<0.05, Kolmogorov-Smirnov test) Fig3.18E,
indicating that reduced GABA:AMPA ratio in DISC1 HET mice is due to smaller feedforward
inhibitory currents.
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Figure 3.18: Reduced feedforward inhibition onto layer III pyramidal neurons in DISC1 +/-
mice. A. Recording scheme: whole-cell patch recordings were performed in layer III PNs in ACC and
monosynaptic AMPA and disynaptic GABA currents recorded following 0.5 ms blue light stimulation of
ChR2+ MD axon terminals. B. Total current evoked by MD axon activation was consistent across WT
and DISC1 HET mice but the % GABA current was significantly reduced (**p<0.01, two-tailed t-test)).
C. GABA:AMPA ratio is significantly reduced in DISC1 HET compared to WT (**p<0.01, two-tailed
t-test)) n= 23, 19 N= 8, 7. D. Representative traces for WT and HET with GABA:AMPA ratios. E.
Cumulative probability distributions for EPSCs and IPSCs show that IPSCs are significantly smaller in
DISC1 HET mice compared to WT (*p<0.05, Kolmogorov-Smirnov test). Scale bar = 200 pA, 25 ms
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3.3.12 Conclusions
We characterized a projection from the MD thalamus to the ACC that recruits direct excitatory
input and feedforward inhibition onto layer III pyramidal neurons. Several results argue that
MD-evoked IPSCs are disynaptic and mediated by PV INs.
1) PV INs receive direct excitatory input from the MD; these thalamocortical EPSCs
exhibit shorter onset latency and faster kinetics than layer III pyramidal neurons. Furthermore,
MD synaptic input is stronger onto PV INs than neighboring PNs.
2) The jitter of onset latency for MD-evoked IPSCs is sufficiently low (∼0.4 ms) to argue
that it is mediated by PV INs that receive direct excitatory input from the MD, rather than
polysynaptic recruitment by local PNs.
3) PV INs spike in response to MD axon stimulation. Furthermore, PV spike probability
is related to spike onset latency in a manner that is consistent with the IPSC onset delay shift
observed between minimal (<50% probability) and reliable MD-evoked IPSCs. Furthermore,
PV INs spike within a time frame that is consistent with the onset of MD-evoked IPSCs, while
all SST INs we recorded spike too late to mediate the short-latency MD-evoked IPSCs.
4) Lastly, and most importantly, optogenetic silencing of PV INs dramatically reduced
or abolished MD-evoked IPSCs, while silencing SST INs did not.
As far as I’m aware, the data presented here are the first to demonstrate that MD di-
rectly recruits PV INs in the dACC. This data confirms ultrastructural findings (Kuroda et al.,
2004; Rotaru et al., 2005), and provides a potential mechanism for MD inhibitory gating of PFC
responses to hippocampal stimulation (Floresco & Grace, 2003). In addition, the recruitment of
feedforward inhibition from the thalamus to the PFC may have significant implications for the
role of the MD-ACC pathway in working memory. Because GABA transmission is important
for PFC-dependent cognitive function (Enomoto et al., 2011; Sawaguchi et al., 1989) and MD
has been shown to be important for several aspects of executive function, it may follow that
optimal processing in the MD-ACC circuit relies on intact feedforward inhibition. In nonhuman
primates, MD transmits delay period tuning to the PFC during an oculomotor task (Funahashi
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et al., 2004; Watanabe & Funahashi, 2012; Watanabe & Takeda, 2009), and GABA signaling
is necessary for the integrity of spatial tuning of delay period neurons in the primate PFC
(Rao et al., 2000). Furthermore, neurons in sensory cortices are predicted to amplify tuned
input from thalamus (Lien & Scanziani, 2013), and it would be predicted that in the MD-ACC
pathway, reduced feedforward inhibition would increase cortical amplification of thalamic input
and compromise spatial tuning. In keeping with this idea, introducing PFC disinhibition into a
computational model of working memory broadened working memory activity patterns and de-
graded the precision of stored information during the delay period (Murray et al., 2014). Given
that findings from SZ patients suggest that the function of PV INs is impaired in DLPFC
(Lewis et al., 2005; Tooney & Chahl, 2004; Woo et al., 1997) and that thalamofrontal con-
nectivity is reduced (Mitelman et al., 2005; Schlosser et al., 2008; Seidman et al., 1994; Zhou
et al., 2007), these abnormalities may interact to dysregulate working memory. In addition,
adolescent maturation events such as myelination and GABAergic maturation could enhance
underlying alterations in the MD-PFC circuit, and thus exacerbate cognitive symptoms during
the prodromal phase of SZ.
Optogenetic silencing of PV+ interneurons revealed their function in sharpening layer
III pyramidal neuron responses to thalamic input. The duration of EPSCs and PSPs was
prolonged when PV interneurons were silenced just prior to MD axon stimulation. The removal
of PV mediated feedforward inhibition increased the temporal window during which layer III
pyramidal neurons could integrate excitatory input as evidenced by increased EPSC half-width.
In one notable case, halorhodopsin activation in PV interneurons caused previously subthreshold
stimulation to elicit action potentials. Meanwhile, SST silencing had no effect on integration
time, consistent with what is known about the presynaptic properties of thalamic inputs onto
PV vs. SST INs: namely, that thalamic synapses onto PV INs rapidly depress while synapses
onto SST INs exhibit weak responses that facilitate during repetitive activity in vitro (Beierlein
et al., 2003; Cruikshank et al., 2010; Tan et al., 2008; Xu et al., 2013) and in vivo (Ma et al.,
2010). Therefore, the single brief light pulse used in our stimulation protocol was unlikely to
drive SST IN firing directly and thus contribute to feedforward inhibitory currents. This is
consistent with our data recording cell-attached spikes in PV vs. SST INs: SST spikes occurred
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∼14 ms after PV spikes, and exhibited more jitter, suggesting that they fired in response to
polysynaptic excitatory input rather than direct thalamic input.
In one of my halorhodopsin experiments, I used the SST-IRES-Cre line to silence the
major non-PV+ inhibitory IN class found in the thalamorecipient cortical layers (constituting
20-30% of GABAergic INs) (Rudy et al., 2010). It was previously discovered that there is a
subpopulation of SST INs that overlap with layer IV INs labeled by the X94 transgenic mouse
line that have the unique ability to target fast-spiking INs (Xu et al., 2013). Therefore, it’s
possible that the potentiation of MD-evoked IPSCs that I saw upon silencing SST INs is due to
the removal of a source of inhibition onto PV INs. It is still unclear, however, to what extent the
organization of the thalamocortical microcircuit is conserved between granular and agranular
cortex (like the mPFC). In none of the experiments I’ve performed thus far have I manipulated
SST INs and recorded from a PV IN or vice versa. This type of experiment would shed light on
whether SST INs can directly influence the response of PV INs to MD axon stimulation.
While we demonstrate that MD recruits short latency, reliable PV-mediated inhibition
onto layer III pyramidal neurons, our PV rabies tracing clearly shows that MD is not the only
upstream afferent that recruits PV INs in the mPFC. Ultrastructural studies have demonstrated
that both BLA and hippocampal afferents terminate onto PV INs (Gabbott et al., 2002, 2006).
Consistent with this finding, it was shown that pharmacological inactivation of ventral hip-
pocampus led to reduced firing rates of inhibitory interneurons in mPFC (Sotres-Bayon et al.,
2012). In fact, I have also observed disynaptic inhibition recruited by stimulating BLA termi-
nals under similar conditions see Appendix Fig. 2A-D. I observed that the synaptic latencies
for BLA-evoked EPSCs and IPSCs were nearly identical to those seen in the MD-BLA path-
way Fig. 2C. The mean latency of BLA-evoked EPSCs onto layer II/III pyramidal neurons
in dACC was 4.8 ± .19 ms compared to 4.6 ± .14 ms observed for MD-evoked EPSCs onto
layer III pyramidal neurons (p>.05 two-tailed paired t-test; n= 42, 25). The mean latency of
BLA-evoked IPSCs was 9.7 ± .27 ms compared to 9.5 ± .16 ms for MD-evoked IPSCs (p>.05
two-tailed paired t-test; n= 17, 59). I also observed that PV INs in layer II/III receive direct
excitatory input from BLA afferents Fig. 2D. It is difficult to draw comparisons between the
BLA and MD stimulation data, as the recording parameters were slightly different (1 ms vs. 0.5
113
ms light stimulation, Cs-based internal solution vs. K-based internal solution). However, I did
notice that the amplitude of BLA-evoked EPSCs onto PV INs were rather small; even with high
intensity light stimulation, the average amplitude was -28.8 ± 4.3 pA (n= 5, N= 2). Future
studies could compare the relative strength of PV input/feedforward inhibition recruitment in
different projections, possibly with the use of shifted channelrhodopsins.
The second major finding of this section is that the ratio of GABA : AMPA currents
evoked by MD axon stimulation was reduced in the DISC1 HET mice. This is the first physiolog-
ical demonstration that E/I balance is altered in the DISC1 mouse model. The most consistent
findings from DISC1 mouse studies is impaired working memory performance (typically using
the DNMS task) and reduced PV expression in the mPFC (Ayhan et al., 2010; Brandon &
Sawa, 2011; Clapcote et al., 2007; Hikida et al., 2007; Koike et al., 2006; Kvajo et al., 2008;
Niwa et al., 2010; Shen et al., 2008). Interestingly, reductions in PV staining were observed in
models where DISC1 expression was manipulated in pyramidal neurons alone (Hikida et al.,
2007; Niwa et al., 2010), suggesting that PV dysfunction may be secondary to primary changes
in pyramidal neurons. One possibility is that impaired neuronal differentiation and migration
of pyramidal neurons affects PV INs integrate into the local circuit. The DISC1 mouse model
that I studied produced a pan neuronal loss of one copy of the DISC1 gene; therefore, different
mechanisms may be at play but it should be noted that the DISC1 LI mouse does display
characteristic impairments in neuronal proliferation and migration. In the second chapter of
my thesis I reported evidence that mIPSC frequency is reduced in the mPFC and PPR of PV-
mediated IPSCs is increased in DISC1 HET mice. It is difficult to know what the relationship
is between PPR and pr (Dobrunz & Stevens, 1997) therefore I am cautious in interpreting the
observed reduction in GABA : AMPA ratio as a consequence of lower pr at PV-PN synapses.
Regardless of the precise mechanism, the data from three separate experiments suggest that
PV-PN transmission is reduced in the DISC1 HET mice and that E/I balance is increased in the
mPFC. It would be interesting to test the working memory performance in the DISC1 LI mice,
as an outstanding question is whether increased E/I impairs working memory. In the future,
in vivo recordings in the DISC1 LI mice may shed more light on circuit perturbations.
There are a few caveats of the data presented. I did not record MD-evoked EPSCs onto
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PV+ INs and PNs in the presence of TTX + 4-AP, which would be a good additional control
to verify that input from MD to these cell-types is monosynaptic as opposed to polysynaptic
(Petreanu et al., 2009). Additional recordings of PV and PN pairs using K-gluconate need to
be performed to complete the datasets for the EPSC kinetics, PV PPR, and relative response
strength. Another experiment that would be informative is paired cell-attached recordings of
PV INs and PNs in response to MD stimulation. The data so far would suggest that PV INs
will have a lower MD-evoked spike threshold, however it will be interesting to track the curves
of light intensity vs. spike probability for PV INs and PNs across genotypes. The initial relative
spike thresholds could help clarify if PV INs are normally recruited by MD axon stimulation
in the DISC1 HET mice. In addition, the slope of PN spike probability may shed light as to
what extent feedforward inhibition curtails PN spikes at low stimulation intensity.
A more general issue with the data may be that we did not standardize the absolute
light power across stimulation trials, though we did maintain the diameter of the light source
across experiments. My argument for not using a consistent light power is that I believe that
the greater source of variability in this type of optogenetic study comes from the viral injection
itself: the precise location and infectivity that subsequently affects the distribution of and ChR2
expression within axons. I believe that maintaining light power has the potential to amplify
these sources of experimental variability. Instead, we adjusted the stimulation intensity based
on each cell’s response properties, such that the maximum short-latency single peak IPSC was
evoked. Generally the GABA : AMPA ratio does not increase linearly because while AMPA
currents increase linearly with light intensity, GABA recruitment is superlinear. Therefore, it’s
important to compare cells within the same stimulation range. One piece of evidence that we
achieved this in our recordings is that the total current evoked by MD stimulation was equal
across genotypes. Therefore it is not the case that we sampled within the “low-end” of the
GABA : AMPA curve and biased the data towards lower ratios in the DISC1 HET mice.
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Chapter 4
Discussion
4.0.13 PV interneuron function in DISC1 LI model
We observed an increase in the paired pulse ratio of PV-evoked IPSCs onto layer III PNs in
the DISC1 HET mice. The difference between DISC1 HET and WT mice was largest at the
shortest interstimulus intervals tested ≤ 100ms. This change in PPR is reminiscent of the
increased facilitation previously observed in PV-/- mice between INs and Purkinje cells within
the cerebellum (Caillard et al., 2000). A similar relationship between PV expression level and
IPSC PPR was observed in barrel cortex of whisker trimmed mice. PV expression was reduced
within the deprived barrels, and typically robust paired-pulse depression was replaced by weak
paired-pulse depression or facilitation (Jiao et al., 2006). Given that reduced parvalbumin
expression within PFC has been observed across various DISC1 mutant mouse models (Ayhan
et al., 2010; Hikida et al., 2007; Lee et al., 2013b; Niwa et al., 2010; Shen et al., 2008) we
are interested in quantifying PV staining in the mPFC of DISC1 HET mice, to determine
if lower expression could contribute to altered short-term plasticity at the PV-PN synapse.
However, even if PV IPSC PPR increases can be “rescued” by overexpression of parvalbumin,
the mechanistic link between DISC1 and parvalbumin is unclear. One hypothesis is that DISC1
deletion could impair neuronal differentiation of PV INs or alter tangential migration of INs
in the cortex or interfere with the final stages of PV IN differentiation: parvalbumin protein
expression appears in the cortex at postnatal day 10 (del Rio et al., 1994). While our observation
of reduced mIPSC frequency onto pyramidal neurons could be consistent with fewer PV INs
rather than changes in the short term dynamics of GABA release, our data from the direct
ChR2 activation of PV INs suggest that GABA release dynamics are altered in the DISC1
HET mice. Whether or not parvalbumin expression plays a role in this change remains to be
determined. Given that the PV-IRES-Cre; Ai14 reporter mice “turn on” by even transient
expression of parvalbumin at P10 (del Rio et al., 1994), it would be interesting to compare the
number of Ai14+ neurons with parvalbumin staining cell counts in adult DISC1 HET and WT
mice. This could address the question of whether fewer PV INs are specified early in brain
development or whether they lose parvalbumin expression later in life, as is believed to be the
case in patients with SZ (Curley et al., 2011).
The unique kinetics of parvalbumin’s Ca2+ buffering ability negligibly influences the
rise rate of intracellular Ca2+ but accelerates the initial decay phase, which limits the buildup
of residual Ca2+ at presynaptic terminals and shifts short term plasticity towards depression
(Muller et al., 2007; Schwaller, 2010). However, a caveat is that the Caillard study was per-
formed in the cerebellum, where PV INs express especially high levels of parvalbumin. A
recent study found no functional difference between PV+ and PV-/- to PN synapses in the
hippocampus, and concluded from modeling that parvalbumin affects synaptic dynamics only
when expressed at high levels (Eggermann & Jonas, 2011).
While facilitation at the PV-PN synapse could suggest an increase in inhibitory trans-
mission, most studies favor the model that reduced PV expression results in a decrease in gamma
band power due to asynchronous GABA release. A computational model of a cortical circuit
including asynchronous release from GABAergic interneurons found that reducing PV levels –
either as a loss of PV interneurons or a constant reduction in PV expression across interneurons
– exhibited a decreased level of excitation and reduced gamma-band activity (Volman et al.,
2011). It was also observed experimentally that PV-/- mice exhibited greater asynchronous
GABA release following high-frequency action potential firing compared to controls (Manseau
et al., 2010). The key feature of this network is that PV INs inhibit one another, such that
asynchronous GABA release caused by an aberrant increase in presynaptic Ca2+ stores would
result in desynchronized PV interneuron firing and reduced gamma power. However, another
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study in PV knockout mice found that if PV-mediated IPSC decays are constant, an increase
in GABA PPR increases gamma power without affecting the dominant frequency or coherence
(Vreugdenhil et al., 2003). Our set of findings is consistent with the model of unchanged PV-
mediated IPSC decay but increased PPR. Given these conflicting results, it isn’t entirely clear
if and how gamma oscillations are altered in the DISC1 HET mice. In the future, it would be
interesting to apply the method developed by Cardin et al. to transduce DISC1; PV-Cre mice
with Cre-dependent ChR2 and measure the tuning curve of the LFP power ratio across a range
of PV stimulation frequencies (Cardin et al., 2009). This method may reveal a more nuanced
picture of the ability of PV firing to induce oscillations across frequency bands. This method
was used to demonstrate that mice in which NR1 is knocked out of PV INs are impaired in
generating oscillations within the gamma band range (Carlen et al., 2012), and will be a useful
tool to test the model predictions of altered PV-PN synaptic properties.
A recent study reported that PV interneurons preferentially target the type A subclass
of layer V pyramidal neurons in mPFC that project subcortically, compared to type B layer
V pyramidal neurons that project to contralateral cortex and striatum (Lee et al., 2014). Our
study did not distinguish between type A and type B pyramidal neurons. However, given that
we focused our recordings in layer III, we are most likely to have recorded type B neurons
(type A are restricted to Vb). In the future it would be interesting to evaluate the contribu-
tion of MD-driven feedforward inhibition to distinct subpopulations of pyramidal neurons; for
instance to type A vs. type B. The development of new genetic intersection lines that capture
subpopulations of pyramidal neurons will aid in this type of study. Another approach would
be to use retrograde tracing in combination with ChR2 in MD in order to target recordings
from pyramidal neurons that project to MD and ask whether they receive direct excitatory
input from MD and compare the GABA:AMPA ratio onto these neurons compared to layer III
PNs. Enhanced inhibition from PV INs onto type B neurons might argue for the importance
of MD-ACC feedforward projections to synchronize activity across ACC and the MD or other
subcortical targets.
Human imaging studies suggest a link between altered MD-PFC functional connec-
tivity and schizophrenia. Analysis of resting-state BOLD MRI suggested reduced functional
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connectivity between the MD and prefrontal cortex in patients with SZ. Interestingly, this was
accompanied by increased functional connectivity between the somatosensory cortex and the
ventral lateral and ventral posterior-lateral thalamus (Woodward et al., 2012). Normally, the
thalamus-somatosensory connectivity exhibits an inverted U shape that peaks in adolescence
compared to childhood and adult and then decreases from adolescence to adulthood. Therefore,
the finding of elevated thalamo-somatosensory connectivity may suggest that there is impaired
circuit refinement during late brain maturation, during the time that schizophrenia most often
has its onset.
Interestingly, resting-state prefrontal-thalamic functional connectivity is largely absent
in children and adolescents and increases from childhood into adulthood (Fair et al., 2010). One
explanation may be increasing myelination over that time period. However, intriguingly it has
been shown in rodent that the number of synaptic contacts onto mPFC GABAergic interneu-
rons from long-range projections increase 8-fold from juvenile to adulthood (Cunningham et al.,
2008). Therefore, another possibility is that the maturation of inhibition in the mPFC shapes
the output of MD-projecting layer V and VI neurons in such a way that increases coherent
activity across these reciprocally connected brain regions, thus increasing MD-PFC functional
connectivity. People diagnosed with SZ have increased fractional anisotropy in white matter
tracts connecting MD to DLPFC, suggesting that reduced functional connectivity is due, at
least in part, to altered white matter properties (Marenco et al., 2012). However, an appeal-
ing explanation that could tie the observed postmortem reductions in markers of inhibitory
transmission with reduced functional connectivity between the MD and DLPFC and abnor-
mal oscillations is that altered inhibitory transmission in PFC leads to weakened reverberatory
activity between the MD and PFC. Although the topic hasn’t been explored very much, at
least one study asked whether lesioning the MD of adolescent rats would produce changes in
inhibitory markers in PFC (Volk & Lewis, 2003). They found no changes in GABA markers,
arguing that impaired GABA transmission in PFC is just as likely a cause as a consequence of
altered MD-PFC connectivity. However, it is possible that MD lesion earlier in development
may have had an effect. The ability of the thalamus to influence cortical patterning early in
development (Pouchelon & Jabaudon, 2014) and its role as a “hub” for information processing
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suggest that thalamic disruption early in life could have profound effects on brain function. No-
tably two recent papers have made interesting findings of aberrant thalamocortical circuitry in
genetic models of neurodevelopmental disease (Chun et al., 2014; Normand et al., 2013).
In addition to functional imaging data, postmortem studies report reduced MD thala-
mic volume (Heckers, 1997; Popken et al., 2000; Young et al., 2000) and cell number (Byne
et al., 2002; Pakkenberg, 1990) in patients with SZ. It is difficult to interpret data collected
from a chronically ill patient population, and it is possible that reduced MD volume is related
to antipsychotic treatment or other comorbidities from which patients with SZ often suffer.
However, in particular, functional imaging studies strongly suggest that communication within
the MD-PFC thalamocortical circuit is altered in SZ. Taken with the evidence for impaired
GABAergic transmission – particularly from PV INs – in the PFC, an intriguing hypothesis is
that PV dysfunction disrupts cortical oscillations in PFC that support cognition. Other higher-
order thalamic nuclei such as the pulvinar have been shown to be important for synchronizing
activity between cortical regions (Saalmann et al., 2012). This synchronization is a mechanism
that could regulate information transfer across brain regions as behavioral or cognitive demands
dictate.
Although highly speculative, it’s interesting to note that chemicogenetic inhibition of
MD reduced coherence of beta oscillations between mPFC and MD during the choice phase
of a delayed nonmatch to sample task. It’s been suggested that IN firing in the gamma band
range can promote beta band oscillations in excitatory populations as excitatory neurons ”skip
a beat” of the gamma oscillation (Kopell et al., 1999). While gamma oscillations (40-80 Hz)
cannot be transferred across brain regions, oscillations in the lower frequency range such as beta
(13-30 Hz), theta (4-12 Hz), and delta (.5-4 Hz) have long conduction delays and are believed
to be better suited to transfer information across long distances (Stein et al., 2000). Because we
observed that MD relay neurons send a significant projection to PV INs in mPFC, inhibiting
MD may alter the strength and/or timing of feedforward inhibition in mPFC and thus alter
the synchrony of neuronal firing in PNs that then project back to MD (Singer, 2009). Recently,
PV IN dysfunction was proposed as a mechanism underlying altered long-range coordination
of delta oscillations during non-REM sleep in the methylazoxymethanol (MAM) E17 mouse
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model of schizophrenia (Phillips et al., 2012).
It would be interesting in the future to explore the role that PFC inhibitory INs play
in supporting cognitive task-related changes in synchronous activity between connected brain
regions. It’s known that fast-spiking PV INs play a major role in generating local gamma os-
cillations, but the mechanism underlying beta frequency oscillations is not yet known. Another
possibility is that beta oscillations aren’t intrinsic to the MD-mPFC circuit but are driven by
brain areas that are upstream of the MD. One such candidate is the globus pallidus, which has
GABAergic interneurons that exhibit oscillatory properties (Stanford, 2003). Given that the
MD is comprised solely of excitatory projection neurons in the rodent, the MD-ACC-MD could
serve as a simplified circuit within which to study the role of local inhibition in the mPFC in
inducing or sustaining long-range synchrony. Again, the recurring theme of altered oscillations
and reduced inhibitory markers in individuals with SZ highlights the need for understanding
the basic mechanisms of rhythm generation in the brain.
4.0.14 Future perspectives
There is debate within the psychiatric research field as to whether a “reverse translational” gene-
to-phenotype approach is the best strategy for understanding the biology underlying human
brain disorders like schizophrenia. For example, despite having known the single causal gene
for Huntington’s disease for over 20 years, little progress has been made towards developing
therapeutics. Schizophrenia, with its complex, gene-by-environment interaction origins is likely
to pose an even greater challenge (Low & Hardy, 2007). Rare schizophrenia risk variants
such as DISC1 and NRG1, while not always supported by genome-wide association studies,
have been shown to regulate important aspects of brain development and synaptic function.
Therefore, from one view, “solving” the puzzle of how DISC1 genomic deletion leads to cognitive
dysfunction can only explain a miniscule fraction of SZ cases. However, if we think of DISC1 –
a rare, but highly penetrant genetic risk factor for SZ — as a tool to study potential common
pathophysiological mechanisms of SZ, then the explanatory power comes not from the gene’s
specific function but rather the effect it has on neural circuits.
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A reduction in parvalbumin mRNA or protein expression is a reproducible finding in
the postmortem brains of patients with SZ. PV IN dysfunction, reported as reduced mRNA
or protein expression, cell numbers, or physiological readouts is a recurring theme in papers
that study psychiatric risk genes or more general environmental stressors such as maternal de-
privation, in utero MAM administration, or PCP treatment (Deidda et al., 2014; Jiang et al.,
2013). These findings suggest that PV INs may be especially sensitive to stress and neurodevel-
opmental perturbation. Furthermore, PV dysfunction appears to disrupt optimal PFC circuit
function that supports working memory and executive function. If PV PFC dysfunction is
sufficient to cause PFC-dependent cognitive impairment, then deficits in WM tasks should be
present across models, irrespective of the human disease they seek to model. Animal studies
that combine genetic risk with environmental stress may be able to enhance the phenotypes
caused by genetic liability alone (Abazyan et al., 2011; Niwa et al., 2013).
In this thesis, I’ve proposed a circuit mechanism by which impaired PV IN function
in the ACC could lead to the impaired function connectivity between MD and PFC seen in
patients with SZ. In the future, I think it will be crucial to study how PV dysfunction can alter
not only the generation of local gamma oscillations, but long range communication across brain
regions. Now that we have shown that MD recruits feedforward inhibition in the ACC, the
question is what role feedforward inhibition plays in non-sensory cortical areas. What do the
receptive fields in the prefrontal cortex represent, and what is the functional consequence of MD-
PV IN feedforward inhibition on these representations? The work of Patricia Goldman-Rakic
suggests that the PFC serves as temporary storage for spatial representations (or motor plans),
however, more recent work suggests that the role of PFC is more complex (Lesh et al., 2010).
For instance, it isn’t known how the PFC represents objects within different contexts. The MD
and PFC are known to be important for flexibly adapting behavior, and the MD appears to
have the makings of a comparator, with its reciprocal connections with the PFC and inputs
from limbic structures that are involved in motivation, motor planning, and reward.
An important goal in the future will be to bridge the gap between synaptic deficits ob-
served in either environmental or genetic models of psychiatric disease with broad, distributed
alterations in brain activity, such as those measured via oscillations. Given the commonly ob-
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served change in PV IN function and abnormal oscillatory activity in schizophrenia, it will be
crucial to understand the neural substrate of frequency bands that are perturbed in schizophre-
nia. In addition, I think it will be fascinating to study the link between postnatal brain
maturation and oscillation development as it’s been shown to develop postnatally (Uhlhaas &
Singer, 2011) and require the maturation of inhibitory circuits (Doischer et al., 2008).
.
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.1 Supplementary figures
A.
B.
Figure 1: Generation of Disc1 locus impairment mice. A. Schematic diagram of exon targeting and
deletion strategy. The genomic regions flanking Disc1 exon 1 and 3 were used as homology arms to
replace the exons 1 to 3 with a neomycin cassette. B. Southern blotting confirms successful targeting
of Disc1 in homozygous mutant (-/-) mice. C. Western blotting using mouse Disc1 antibodies raised
against exons 9-13 (2B3) confirms depletion of the immunoreactivity corresponding to full-length Disc1
isoform.
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Figure 2: BLA inputs to ACC recruit IPSCs with the same latency seen in the MD-ACC
projection. A. Sample AAV-ChR2-GFP injection into the BLA. B. Image of recorded PN in layer
II/II. C. EPSC and IPSC onset latencies are consistent between the MD-ACC and BLA-ACC projection
pathways p>.05. D. Sample trace of BLA-evoked EPSC and IPSC. E. Sample trace of BLA-evoked
EPSC onto superficial PV IN.
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.2 List of abbreviations
AAV . . . . . . adeno-associated virus
ACC . . . . . . anterior cingulate cortex
ACSF . . . . . artificial cerebral spinal fluid
AMPA . . . . . α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANOVA . . . . analysis of variance
AP-5 . . . . . . DL-2-Amino-5-phosphonopentanoic acid
BLA . . . . . . basolateral amygdala
Cdk5 . . . . . . cyclin-dependent kinase 5
Cg . . . . . . . cingulate
ChR2 . . . . . channelrhodopsin-2
CL . . . . . . . centrolateral nucleus of the thalamus
CNO . . . . . . 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e](1,4)diazepine N-oxide
CNQX . . . . . 6-Cyano-7-nitroquinoxaline-2,3-dione
Cre . . . . . . . Cre-recombinase
CTB . . . . . . cholera toxin B (conjugated to Alexa-Flour-555)
DIO- . . . . . . double floxed inverse open reading frame
DISC1 . . . . . Disrupted-in-Schizophrenia 1
DISC1 LI . . . DISC1 locus impairment
Dixdc1 . . . . . DIX domain containing 1
DLPFC . . . . dorsolateral prefrontal cortex
DNMS . . . . . delayed nonmatch-to-sample working memory task
DNMTP . . . delayed nonmatch-to-place working memory task
DREADD . . designer receptor exclusively activated by designer drug
DSM-5 . . . . . fifth edition of the Diagnostic and Statistical Manual of Mental Disorders
E# . . . . . . . embryonic day
E/I . . . . . . . excitation : inhibition
EnvA . . . . . avian sarcoma leucosis virus glycoprotein EnvA
EPSC . . . . . excitatory postsynaptic current
G# . . . . . . . gestational day
GABA . . . . . γ-aminobutyric acid
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GDP . . . . . . guanine diphosphate
GTP . . . . . . guanine triphosphate
Glur1 . . . . . glutamate receptor subunit 1
GFP . . . . . . green fluorescent protein
GSK3β . . . . glycogen synthase kinase 3 beta
hDISC1 . . . . truncated form of human DISC1
HET . . . . . . heterozygous, referring to mice with loss of 1 copy of DISC1
IL . . . . . . . . infralimbic cortex
IN . . . . . . . interneuron
IMD . . . . . . intermediodorsal nucleus of the thalamus
IPSC . . . . . . inhibitory postsynaptic current
IT . . . . . . . . intratelencephalic
KD . . . . . . . knockdown
LFS . . . . . . low frequency stimulation
LO . . . . . . . lateral orbital frontal cortex
LTD . . . . . . long term depression
MAM . . . . . methylazoxymethanol
M2 . . . . . . . secondary motor cortex
MD . . . . . . . mediodorsal nucleus of the thalamus
mPFC . . . . . medial prefrontal cortex
mEPSC . . . . miniature excitatory postsynaptic current
mIPSC . . . . miniature inhibitory postsynaptic current
MRS . . . . . . magnetic resonance spectroscopy
NDEL1 . . . . NudE nuclear distribution E homolog (A. nidulans)-like 1
NMDA . . . . N -methyl-D-aspartate
NpHR3.0 . . . halorhodopsin 3.0
P# . . . . . . . postnatal day
PFC . . . . . . prefrontal cortex
PIT . . . . . . Pavlovian-to-instrumental transfer
PN . . . . . . . pyramidal neuron
PPR . . . . . . paired pulse ratio
PrL . . . . . . . prelimbic Cortex
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PSD95 . . . . . post synaptic density 95
PT . . . . . . . pyramidal tract
PV . . . . . . . parvalbumin
TC . . . . . . . thalamocortical
TRE . . . . . . tetracycline response element
VPM . . . . . . ventral posteromedial nucleus of the thalamus
shRNA . . . . short hairpin RNA
SNP . . . . . . single nucleotide polymorphism
SZ . . . . . . . schizophrenia
t(1;11) . . . . . chromosomal translocation between chromosome 1 and 11
TNIK . . . . . TRAF2 and NCK interacting kinase
TTX . . . . . . tetrodotoxin
TRN . . . . . . thalamic reticular nucleus
TVA . . . . . . avian tumor virus receptor A
vHipp . . . . . ventral hippocampus
VO . . . . . . . ventral orbital frontal cortex
WT . . . . . . . wildtype
ZI . . . . . . . . zona incerta
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